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ABSTRACT

The voltage-gated potassium channel Kv1.2 impacts membrane potential
and therefore excitability of neurons. Expression of Kv1.2 at the plasma
membrane (PM) is critical for channel function, and altering Kv1.2 at the PM is
one way to affect membrane excitability. Such is the case in the cerebellum, a
portion of the brain with dense Kv1.2 expression, where modulation of Kv1.2 at
the PM can impact electrical activity of neurons and ultimately cerebellumdependent learning. Modulation of Kv1.2 at the PM can occur through endocytic
trafficking of the channel; however mechanisms behind this process in the brain
remain to be defined.
The goal of this dissertation was to identify and characterize modalities
endogenous to the brain that influence the presence of Kv1.2 at the neuronal
plasma membrane. Mass spectrometry (MS) was used to first identify interacting
proteins and post-translational modifications (PTM) of Kv1.2 from cerebellar
tissue, and the roles of these interactions and modifications on Kv1.2 function
were evaluated in two studies:
The first study investigated Trim32, a protein enzyme that catalyzes
ubiquitylation, a PTM involved in protein degradation, but also in nondegradative events such as endocytic trafficking. Trim32 was demonstrated to
associate and localize with Kv1.2 in cerebellar neurons by MS, immunoblotting
(IB), and immunofluorescence (IF), and also demonstrated the ability to
ubiquitylate Kv1.2 in vitro through purified recombinant proteins. Utilizing
cultured cells through a combination of mutagenesis, biochemistry, and
quantitative MS, a working model of Kv1.2 modulation was developed in which
Trim32 influences Kv1.2 surface expression by two mechanisms that both involve
cross-talk of ubiquitylation and phosphorylation sites of Kv1.2.
The second study investigated WNK1, a chloride-sensitive kinase which
regulates cellular homeostasis. Using MS, IB, and IF, WNK1 was demonstrated
to associate and localize with Kv1.2 in the cerebellum, and a combination of
mutagenesis and pharmacology in both wild-type and WNK1-knockout cultured
cells produced a working model whereby WNK1 modulates surface Kv1.2.
Activation of the downstream target SPAK kinase, also identified by MS to
associate with Kv1.2 in the brain, by WNK1 was additionally found to influence
the manner of WNK1 modulation of Kv1.2.
In addition to providing new models of Kv1.2 modulation in the brain,
these studies propose novel biological roles for Trim32 and WNK1 that may
ultimately impact neuronal excitability.
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW
Proteins are essential to life, and how proteins contribute to cell function is a
fundamental question in science (Eisenberg, Marcotte, Xenarios, & Yeates, 2000).
Around the turn of the 21’st century, large-scale genomic sequencing facilitated the
development of computational methods to identify shared functional properties among
proteins, often by inference from sequence and structural homology (Eisenberg et al.,
2000). However, these methods can be limited by the fact that an individual protein’s
function is often critically dependent on the larger protein complex in which it is found as
well as on its post-translational modification state (Gingras, Gstaiger, Raught, &
Aebersold, 2007; Spirin & Mirny, 2003; Stoilova-McPhie, Ali, & Laezza, 2013). Mass
spectrometry (MS) is a tool that can provide information about both of these key
parameters. Indeed, MS is now perhaps the best method for identifying the specific
components of a protein complex, as well as the specific sites and types of posttranslational modification, that actually exist in living organisms (Aebersold & Mann,
2003). As with any tool, protein peptide identification by MS is not without
shortcomings, drawbacks, and pitfalls, particularly at the level of analysis, (Lubec and
Afjehi-Sadat, 2010) and careful considerations must be made during sample preparation
and analysis. Given this strength of MS, this approach was used as a starting point and
foundation for the data presented in Chapters 2 and 3. Both chapters present evidence for
unique regulation and trafficking of voltage-gated ion channels; Chapter 2 presents data
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for regulation by ubiquitylation and the ubiquitin ligase Trim32 while Chapter 3 presents
data for regulation by atypical WNK1 and SPAK kinases. The following literature review
is intended to provide additional background for the major topics discussed in the
chapters that follow.
Protein Post-Translational Modification
Overview of Protein Post-Translational Modification
Protein function is often regulated by some type of post-translational
modification. Extracellular and intrinsic signals are modulated and fine-tuned by PTMs,
which regulate protein functioning, trafficking, and survival. PTMs also can assist with
general biological processes such as cell signaling, proliferation, migration, and
interaction with other cells (Doerig, Rayner, Scherf, & Tobin, 2015). PTMs can occur at
any point in the life cycle of the protein.
Shortly after translation, PTMs can assist with the proper folding, stability, and
biosynthetic trafficking of proteins (Dunham et al., 2012). Once properly folded and
localized, PTMs can continuously influence the catalytic and overall biological activity of
the protein. Once a protein reaches the end of its life cycle, PMTs serve as tags to mark
its eventual destruction. Ultimately, PTMs impact a protein throughout the entirety of its
lifespan.
The human proteome consists of enzymes such as kinases, phosphatases,
transferases, ligases, and others which perform over 200 types of PTMs by adding,
removing, or transferring modification groups. Examples of PTM modification groups
include: addition of methyl and acetyl groups to a lysine for histone code development on
2

chromatin, palmityl groups to a cysteine to help drive protein association with
membranes, N-acetylglucosamine to a serine/threonine to control enzyme activity and
gene expression in glucose homeostasis, among many others (Pawson & Nash, 2003).
The following sections will focus on two of the most common PTMs, phosphorylation
and ubiquitylation, which influence the dynamic trafficking of mature proteins at the
plasma membrane.
Protein Phosphorylation
Phosphorylation is the most prevalent and understood post-translational
modification. Approximately one-third of proteins in the human proteome are estimated
to be a substrate for phosphorylation at some point in the protein lifespan (P. Cohen,
2000). Protein phosphorylation is the process of attaching the chemical phosphate group
(PO43-) to a protein. In Eukaryotic cells, phosphorylation occurs primarily on a serine,
threonine, or tyrosine but in some rare cases also histidine and aspartate (Thomason &
Kay, 2000). Attachment of the phosphate group alters the proteins electrostatic properties
and often induces a conformational change that alters activity and/or recruit of
downstream proteins. The effects of phosphorylation on protein function are varied, and
multiple modifications within a single protein can lead to complex outcomes (Barford,
Das, & Egloff, 1998; Pawson & Nash, 2003; Pellicena & Kuriyan, 2006).
Protein Kinases
A protein kinase is responsible for transferring the phosphate group to a protein
substrate. Protein kinases are involvement in coordination of nearly every cellular
process, as the activity, localization, and overall function of many proteins is directed by
3

kinase phosphorylation. Protein kinases deliver a single phosphoryl group from ATP to
the ɤ position to the hydroxyl group (-OH) oxygen on a serine, threonine, or tyrosine side
chain of a protein. This process can be rapidly reversed by protein phosphatases which
remove the phosphate group and release it back into solution. Together, protein kinases
and phosphatases provide a back and forth mechanism that dynamically regulates the
homeostasis of a protein’s phosphorylation state (collectively reviewed in (Cheng, Qi,
Paudel, & Zhu, 2011)).
Approximately 2% of human genes encode for protein kinases. Of the 518 protein
kinases, 478 belong to a single superfamily with related catalytic domain sequence
(Manning, Whyte, Martinez, Hunter, & Sudarsanam, 2002). Various kinase classification
methods have been developed, most of which separate them into groups and families
based on similarity of sequence and biochemical functionality (Martin, Anamika, &
Srinivasan, 2010).
Protein kinases are highly conserved throughout evolution. Prior to the discovery
of atypical kinases, one of the many conserved subdomains encompassing the catalytic
core, subdomain II, contains a lysine residue that was, at the time, present in all protein
kinase catalytic domains. Mutation of this lysine can render a kinase catalytically
inactive, which is also proximally close to the ATP molecule and suggested to be
involved in the stabilization and binding of ATP and the phosphate transfer process. This
invariant lysine was described as crucial for binding ATP (Carrera, Alexandrov, &
Roberts, 1993). At the turn of the century, however, a new group of kinases were
discovered that appeared to catalyze phosphorylation without this crucial lysine.
4

Atypical WNK Protein Kinases
WNK (With-No-Lysine) kinases are a four member group (WNK1-4) of atypical
serine/threonine protein kinases. Their atypical subcategorization results from the unusual
placement of the conserved, catalytic lysine of subdomain II that is replaced by a cysteine
residue (Figure 1). The group that first characterized these kinases originally believed the
catalytic lysine was simply missing and called them “With-No-Lysine” (B. Xu et al.,
2000). However, within the same initial study, the group also determined lysine 233
(K233) in human WNK1, which is found within kinase subdomain I and conserved
across all WNK homologs, is critical for catalytic activity, and mutation of this lysine to
methionine disrupted kinase activity (B. Xu et al., 2000). The crystal structure of WNK1
later showed that the folding structure of active WNK1 actually positions K233 to a
location analogous to the lysine normally conserved within subdomain II, and that
inactive WNK1 actually adopts a conformation that pulls the lysine out of catalytic
position (Min, Lee, Cobb, & Goldsmith, 2004). WNK1 remains the best characterized of
the four isoforms. The functional role of WNK kinases within human renal function has
been the focal point of WNK research and often acts as a model for WNK signaling in
other systems.

5

Figure 1:1 Structure of WNK1. Top: Highlights the kinase domain and length of
WNK1. Bottom: Ribbon representation of the crystal structure of the WNK1 highlighting
the unusual placement of the catalytic lysine, K233, which is found within β strand 2
rather than strand 3 of other kinases. The red circle highlights K233 and the typical lysine
location where, instead, a cysteine is found (C250).
Image adapted with permission from work published by Min et al. Crystal Structure of the Kinase
Domain of WNK1, a Kinase that Causes a Hereditary Form of Hypertension. Structure. 2004 July;
12(7) 1303-1311.

WNK Signaling in the Kidney
WNK kinases maintain cellular homeostasis by sensing changes in intracellular
chloride, cell volume, and extracellular osmolarity, and respond by adjusting the transport
of sodium (Na+), potassium (K+), and chloride (Cl-) through regulation of reciprocal
cation-chloride co-transporters (CCC) (reviewed collectively in (Alessi et al., 2014)). In
6

the distal convoluted tubule of the kidney, WNK kinases are highly expressed where they
sit atop of a signaling pathway in the regulation of CCCs.
WNK kinases influence cation-co-transporters through activation of immediately
downstream SPAK/OSR1 kinases (Figure 2). SPAK and OSR1 associate with both
WNKs and CCCs by docking their conserved carboxyl-terminal domain (CCT) with
RFXV/I motifs on WNKs and CCCs. Association of WNKs with SPAK/OSR1 allows
WNKs to phosphorylate and activate SPAK/OSR1, while association of SPAK/OSR1
with CCCs allows SPAK/ORS1 to phosphorylate and traffic CCCs. Members of the
WNK family bind SPAK/ORS1 differently, however, and can have different impacts on
cellular signaling. For example, WNK1 phosphorylates and activates SPAK/OSR1 up to
10 fold more than WNK4 (Bazua-Valenti & Gamba, 2015), and its SPAK induced
activation of NCC can be antagonized by WNK4 (Chavez-Canales et al., 2014). Aside
from regulating cation transport through SPAK/OSR1 induced CCC trafficking, WNK
kinases can traffic other proteins, such as ion channels, without the aid of SPAK/OSR1
activation.
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Figure 1:2 Proposed mechanism by which the WNK-SPAK/OSR1 signaling
pathway regulates salt re-absorption and blood pressure. Osmotic stress can trigger
WNK1 to induce trafficking of cation co-transporters through activation of downstream
SPAK/OSR1. This process occurs by a series of phopshorylations: osmotic stress induces
autophosphorylation and activation of WNK1, and activated WNK1 phosphorylates
SPAK/OSR1 which, in turn, phosphorylates and trafficks cation-cotransporters. WNK4
can oppose this process.
Image obtained with permission from work originally published by Ciaran Richardson, and Dario R.
Alessi. J Cell Sci. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1
signalling pathway. 2008;121:3293-3304
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Protein Trafficking by WNK kinases Beyond Cation-co-transporters
WNK-SPAK regulation of CCCs in the kidney is rather well established, however
the WNK-SPAK kinase network has been shown to influence other protein trafficking.
WNK kinases activate endocytosis of renal outer medullary potassium (ROMK)
channels, inward-rectifier potassium (Kir) which transport K+ out of cells (Zagorska et
al., 2007). SiRNA knockdown of endogenous WNK1 in cultured cells increases ROMK1
surface expression, and it was demonstrated that a complex of WNK1-WNK4 binds the
endocytic scaffolding protein intersectin to induce clathrin-dependent endocytosis of
ROMK1 independent of SPAK/OSR1 (He, Wang, Huang, & Huang, 2007; C. L. Huang,
Yang, & Lin, 2008; Lin, Yue, Zhang, & Wang, 2014). Additionally, WNK4 inhibits renal
large-conductance Ca(2+)-activated K(+) (BK) by reducing their surface and whole cell
expression through enhanced ubiquitination mediated lysosomal degradation (Z. Wang et
al., 2013; Yue, Zhang, Lin, Sun, & Wang, 2013), while in contrast, WNK1 enhances BK
channel function by reducing lyosomal degradation (Y. Liu et al., 2015). WNK1 also
activates the serum and glucocorticoid-regulated kinase 1 (SGK1) to enhance activation
of the epithelial sodium channel (ENaC) (B. E. Xu, Stippec, Chu, et al., 2005; B. E. Xu,
Stippec, Lazrak, Huang, & Cobb, 2005). Together, these examples demonstrate that in
addition to CCCs, WNK kinases can also traffic ion channels.
WNK Expression and Connection to Hypertension
WNK1 is expressed ubiquitously in mice as early as embryonic days E8-9 with
enrichment in the cardiovascular system. During development, WNK1 knockout mice
have cardiac deficits and impaired angiogenesis as early as E10.5 and failed vascular
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system remodeling leads to death in utero by E13.5 (Delaloy et al., 2006; J. Xie et al.,
2009). Interestingly, the angiogenic and cardiac defects were nearly identical in global
and endothelial-specific OSR1 knockout mice, and knockin of endothelial-specific
constitutively active OSR1 rescued the defects (J. Xie, Yoon, Yang, Lin, & Huang,
2013), demonstrating that the WNK-SPAK/OSR1 signaling pathway is crucial for proper
development.
As demonstrated by the transgenic mouse models, altered expression of kinases
within the WNK signaling pathway can have severe physiological consequences, and
likewise can impact human health. Mutations in the WNK1 and WNK4 genes cause a
type of hereditary hypertension known as pseudohypoaldosteronism type II (PHAII)
(reviewed in (Bazua-Valenti & Gamba, 2015)). Patients with PHAII have disrupted
regulation of ion transport, resulting in hypertension, hyperkalemia, and hyperchloremic
metabolic acidosis. Overall, conditions that result in increased expression of WNK
kinases seem to result in PHAII (Susa et al., 2014).
Clinical features of PHAII can be explained by impaired ubiquitylation of WNK
kinases (Shibata, Zhang, Puthumana, Stone, & Lifton, 2013). WNK4 reduces surface
expression of ROMK, and ubiquitylation of WNK4 signals kinase degradation and results
in increased ROMK at the surface. A mouse model for PHAII where mice have a singlecopy BAC transgene including the human genomic locus containing the WNK4 Q562E
allele present hypertension and hyperkalemia similar to humans with the same mutation.
These mice were found to have significantly higher levels of WNK4 in the distal nephron
in the kidney compared to mice expressing WNK4WT, and the increased WNK4 was
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reported to be from impaired degradation. Increased WNK4 will result in a relative
elimination of ROMK, a trait that contributes to hyperkalemia in PHAII (Lalioti et al.,
2006). Similarly to genetic mutations impairing WNK4 degradation, genetic mutations
that disrupt the catalytic activity of the ubiquitin ligases that catalyze WNK4
polyubiquitylation cause PHAII. In fact, within a study of 52 families with PHAII, ~80%
of the disease was caused by ubiquitin ligase mutation. Therefore, although PHAII is
attributed to the change in expression and activity of kinases, ubiquitin ligases are the
primary culprits behind the disease (Herrera & Coffman, 2013).
Protein Ubiquitylation
Following phosphorylation, recent advances in proteomics have identified
ubiquitylation (or ubiquitination) as one of the next most abundant and versatile PTMs in
mammalian tissue (W. Kim et al., 2011). In a similar historical context to
phosphorylation (reviewed in (P. Cohen, 2002)), several decades following the discovery
of ubiquitin passed before its functional role breached confinement of a single signaling
mechanism in the scientific literature, however ubiquitylation is now accepted as a major
signaling event involved with a myriad of biological events (Chen & Sun, 2009;
Komander, 2009).
Protein ubiquitylation involves the attachment of the ubiquitin protein to a protein
substrate. Discovered by Hershko and colleagues in 1978, the small ubiquitin protein was
originally reported as a required component for the proteasome to breakdown proteins in
cell extracts (Ciehanover, Hod, & Hershko, 1978). Aaron Ciechanover, Avram Hershko
and Irwin Rose were later awarded the Nobel Prize in Chemistry in 2004 for this
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discovery (Giles, 2004). Work particularly within the lab of Varshavsky and colleagues
in living mammalian cells throughout the 1980s caused a radical change in the general
understanding of intracellular circuits, as they identified the ubiquitin system was
essential for the majority of protein degradation in living cells, required for cell viability,
and performed major roles in the cell cycle, DNA repair, protein synthesis, transcriptional
regulation, and other processes (reviewed in (Varshavsky, 2006)). These discoveries
sparked a massive expansion of the ubiquitin field in the 1990s. Now, ubiquitylation has
been demonstrated to assist orchestrating a plethora of physiological functions.
Ubiquitin-protein ligation requires three enzymes (Hershko, Heller, Elias, &
Ciechanover, 1983) in a three step, sequential action: First, a ubiquitin-activating enzyme
(or E1) utilizes ATP to activate the C-terminal glycine reside of ubiquitin (release of PPi
and AMP). Next, activated ubiquitin is then transferred to an active-site cysteine reside of
a ubiquitin-conjugating enzyme (or E2). Finally, ubiquitin is transferred to a ubiquitinligating enzyme (or E3) which ligates the C-terminal glycine residue of ubiquitin in an
amide isopeptide-linkage to the ɛ-amino group of an internal lysine or α-amino group of
the N-terminal methionine residue in the target protein (Hershko & Ciechanover, 1998).
The covalent bond between substrate lysine and ubiquitin glycine has been
fruitful for modern proteomic identification of ubiquitylation, as ubiquitylated proteins
digested with trypsin (a serine protease which cleaves the carboxy-terminal end of lysine
and arginine amino acids) will result in peptides still containing -K-ε-GG motif following
cleavage of bound ubiquitin from -K-ε-GG(cut)-R-ubiquitin. In addition to the diagnostic
advantages of this 114.0429 Da motif, anti-K-ε-GG antibodies have allowed advanced
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enrichment of ubiquitylated proteins prior to digest and greatly expanded the detected
sites among the literature yielding over 10,000 unique sites on over 4,000 proteins (W.
Kim et al., 2011; Udeshi et al., 2013; Wagner et al., 2012). This approach has led to
similar growth in depth of global phosphorylation and acetylation studies (Choudhary et
al., 2009; Huttlin et al., 2010; S. C. Kim et al., 2006; Olsen et al., 2006).
Ubiquitylation, like phosphorylation, is a reversible process and undergoes
counter regulation by the activity of isopeptidases known as deubiquitinating enzymes
(DUBs) (Clague, Coulson, & Urbe, 2012) that function analogously to the removal of
phosphate by protein phosphatases. An estimated 100 deubiquitinating enzymes within
mammalian cells reverse ubiquitylation by rapidly removing ubiquitin from substrates at
various signaling checkpoints and recycle ubiquitin for further modification (ReyesTurcu, Ventii, & Wilkinson, 2009). Activity coordination between the E3 ligases and
deubiquitinating proteins are then recognized by a plethora of effector proteins with
ubiquitin-binding domains (UBD) which bind non-covalently through the various surface
patches of ubiquitin for various further processing (Clague, Liu, & Urbe, 2012; Hershko
& Ciechanover, 1998; Rahighi & Dikic, 2012). DUBs enable tight regulation of the
ubiquitin signaling events (Hershko & Ciechanover, 1998).
Polyubiquitylation
Ubiquitin binds a substrate classically through covalent attachment of it’s Cterminal carboxylate group to a target lysine. Ubiquitin, an 8.5kDa, 76 amino acid long
protein, can also be a substrate for ubiquitin binding, as seven amino acids in the
sequence of ubiquitin are a lysine.
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Ubiquitylation has many different forms. The seven lysines K6, K11, K27, K29,
K33, K48, and K63 as well as an amino-terminal methionine are all potential substrates
for ubiquitylation, and successive addition of ubiquitin by E1, E2, and E3 enzymes,
collectively referred to as polyubiquitylation, result in ubiquitin chains varying in length,
topology, and proximal moiety (the lysine of chain origin). All seven lysines reside on
different surfaces of ubiquitins tertiary structure (Figure 3).
Each of the polyubiquitin moieties form unique overall structure among the
continuous ubiquitin-ubiquitin linkages. Polyubiquitylation chains form endogenously in
homogenous chains (e.g. all K48 linkages) with heterogeneous chains being currently
speculative. All linkage types are thought to exist within all cells at various abundances
(Pickart & Fushman, 2004; Y. Wang, Tang, Wang, & Wang, 2014). Approximately half
of the populated linkage types are K48 and K63.
Lysine 48 Polyubiquitylation Chains and Degradation
In 1989, a ubiquitin chain with distinct topology of isopeptide bonds on K48 was
discovered, and the poly-ubiquitylation chain was proposed to bind a substrate to the
proteasome (later shown to be the 26S proteasome) and be essential for its degradation
(Chau et al., 1989). Polyubiquitylation at K48 is well characterized as a molecular tag for
degradation by the 26S proteasome. Destruction is carried out by proteolysis of a protein
tagged by a lysine chain of at least four (Thrower, Hoffman, Rechsteiner, & Pickart,
2000) tightly packed, compact globular conformation which the proteasome recognizes,
removes the ubiquitin for recycling, and ubiquitylated peptides are permitted to enter the
barrel-shape structure where the central proteolytic core chops the protein into smaller
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peptides of 3-25 amino acids (Hershko & Ciechanover, 1998). These oligopeptides are
then released into the cytoplasm or nucleoplasm and can be further digested to single
amino acids by various soluble peptidases (reviewed in (Korolchuk, Menzies, &
Rubinsztein, 2010)).
Intriguingly, ubiquitylation can also target substrates for degradation by
autophagy-lysosome destruction, a degradation signaling pathway often thought to
provide bulk, nonspecific degradation (including entire organelles) (Ciechanover, 2005).
Autophagy is a vesicular trafficking pathway limited to the cytoplasm and capable of
degrading a wider spectrum of substrates than a proteasome. Although little mechanistic
similarities occur, these two pathways of degradation share the ability to degrade soluble,
unfolded polypeptide chains (Ding & Yin, 2008). In the 1990s it was discovered that
lysosomes can degrade proteasomal subunits (Cuervo, Palmer, Rivett, & Knecht, 1995),
causing autophagy-lysosome degradation to be hypothesized as a means of controlling
cellular concentration of proteasomes (Korolchuk et al., 2010).
During selective autophagy, like the ubiquitin-proteasome system, it is
ubiquitylation that tags a target for degradation. Unlike the UPS, however, substrates
recognized for autophagy-lysosome degradation are signaled through K63
polyubiquitylation chains (Welchman, Gordon, & Mayer, 2005).
Lysine 63 Polyubiquitylation Chains
Ubiquitin-conjugates with K63 chains were originally reported in the mid-1990s
(Galan & Haguenauer-Tsapis, 1997; Spence, Sadis, Haas, & Finley, 1995). K63
polyubiquitin chains, although also capable of lysosomal and proteasomal degradation
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signaling, (Saeki et al., 2009), are well defined to contribute to a variety of cellular events
including DNA repair, signal transduction, receptor endocytosis, and kinase activation
(reviewed in (Chen & Sun, 2009)). K63 branches were demonstrated to facilitate and
stimulate endocytosis (Galan & Haguenauer-Tsapis, 1997). Although K63 can catalyze
degradation, essential roles for K63 in cell signaling are considered its more primary
function.
Atypical Polyubiquitylation
In contrast to K48 and K63, the cellular roles of atypical polyubiquitylation e.g.
K6, K11, K27, K29, K3, and M1 have yet to be clearly elucidated (reviewed in (Kulathu
& Komander, 2012)). K29 branches have been detected in yeast and mammals, and can
be generated in vitro, but little is known regarding any bio functional signaling
(Kristariyanto et al., 2015). K11 branches have been shown to provide signals for control
of the cell-cycle and innate immune response (Castaneda, Kashyap, Nakasone, Krueger,
& Fushman, 2013; Matsumoto et al., 2010; Rape, 2010; Wickliffe, Williamson, Meyer,
Kelly, & Rape, 2011; Wu et al., 2010). In addition to internal lysines, the amino-terminal
methionine of ubiquitin can also be a substrate for ubiquitylation. These M1 linkages,
assembled by the linear ubiquitin assembly complex (LUBAC) are involved with diverse
signaling processes that are not yet clearly defined (reviewed in (Rieser, Cordier, &
Walczak, 2013)).
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Figure 1:3 Ubiquitin and its lysine residues. The ribbon model of ubiquitin structure
highlights the seven lysines residing on different surfaces of its tertiary structure. The
linking point in linear chains, M1, is spatially close to K63. Red numbers in parenthesis
indicate relative abundance detected in s cerevisiae.
Image obtained with permission from work originally published by David Komander. The emerging
complexity of protein ubiquitination. Soc. Trans. 2009;37:937-953. © The Biochemical Society.

Monoubiquitylation
Although polyubiquitylation remains the forefront for ubiquitylation research,
monoubiquitylation is also biologically significant for DNA repair, viral budding, and
endosomal sorting. Monoubiquitylation, like K63 polyubiquitylation, can also signal
endocytosis of membrane proteins. Monoubiquitylation can also work in conjunction
with other PTMs to direct the localization of proteins to particular cellular compartments
(Hicke, 2001; Mosesson & Yarden, 2006). Recent MS studies designed to identify the
types of ubiquitin chains on ubiquitylated proteins have revealed that monoubiquitin is
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more common than previously assumed. Using anti-K-ε-GG antibodies, one study
extended the ubiquitin-modified proteome (ubiquinome) by identifying ~19,000 ubiquitin
binding sites of ~5,000 proteins (originally determined to be 1,075 proteins with 100
sites) while also reporting that the majority are subject to non-degradation signaling
ubiquitylation (W. Kim et al., 2011; Peng et al., 2003). During the same year, another
study demonstrated that ~ 50% of conjugated ubiquitin is bound to substrates as mono or
multiubiquitin (Ziv et al., 2011).
Outside of the nucleus, monoubiquitylation serves to direct endocytosed,
modified proteins to specific subcellular locations (reviewed in (Haglund, Di Fiore, &
Dikic, 2003)) and endocytic regulators themselves also undergo monoubiquitylation that
work to couple substrate recruitment to the ubiquitylation reaction (coupled
monoubiquitylation) through use of their ubiquitin binding domains (Polo et al., 2002;
Woelk et al., 2006). However, a growing body of literature shows that
monoubiquitylation can also be directly involved in the endocytic trafficking of
membrane proteins such as ROMK1, which has been reported to decrease surface but not
total expression following channel monoubiquitylation (Lin et al., 2005). Altogether,
ubiquitylation can modulate membrane proteins in a variety of ways, including endocytic
trafficking. Consequently, like protein kinases, the enzymes responsible for catalyzing
ubiquitylation have important roles in regulating protein function.
E3 Ubiquitin Ligase Structure and Function
Ubiquitylation is catalyzed by the sequential action of three enzymes collectively
referred to as E1, E2, and E3 in a three step process where the reaction catalyzed by each
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enzyme involves the transfer of a covalent bond with ubiquitin to either the next enzyme
or, finally, the substrate. E1 ubiquitin-activating enzymes utilize ATP-Mg2+ to charge and
form a thioester bond with ubiquitin. Charged ubiquitin is then subsequently passed along
to a second E2-conjugating enzyme and finally the carboxy-terminus of ubiquitin forms
an isopeptide bond with the lysine of a protein substrate. During this process, E3ubiquitin ligases provide the substrate recognition for ubiquitylation. E3s recruit E2s,
recognize the substrate, and directly catalyze or assist the transfer of ubiquitin from E2 to
the substrate. The human genome encodes one E1, about 40 E2, and around six hundred
E3 enzymes (W. Li et al., 2008). In humans, the over 600 E3 ligases are categorized into
4 groups based of their structural motif: HECT-type, RING-finger-type, U-box-type or
PHD-finger-type, with HECT and RING being the two major types of E3’s in eukaryotes
(reviewed in (Hou & Deng, 2015; W. Li et al., 2008; Nakayama & Nakayama, 2006)).
Although four structural categories exist, E3 ubiquitin ligases are generally classified into
two families, HECT-type or RING-type, based on their function. HECT-type E3s have a
conserved cysteine residue that accepts ubiquitin from E2~Ub forming an E3~Ub
thioester. Ubiquitin is then transferred from this covalent E3 intermediate to substrate in
contrast to RING-type E3s which catalyze the direct transfer of ubiquitin from E2~Ub to
substrate (Figure 4).
HECT-type Ubiquitin Ligases
Homologous to the E6-AP Carboxyl Terminus (HECT)-type ubiquitin ligases
consist of a small class of E3 ligases which share C-terminal HECT domains that are
functionally similar to the cellular protein E6-AP (or UBE3A), the E6 protein of the
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cancer-associate human papillomavirus type 16 and 18 which targets p53 for degradation
by ubiquitylation. HECT E3s covalently bind ubiquitin by a cysteine residue in the
catalytic domain and shuttle it onto the target substrate (Huibregtse, Scheffner,
Beaudenon, & Howley, 1995). The HECT domain is composed of an N-terminal lobe for
E2 binding and a smaller C-terminal lobe that contains the catalytic cysteine for ubiquitin
accepting. A flexible hinge region lies between the N- and C- terminal lobes that bridges
the lobes and allows E2 and E3 catalytic sites to be brought close together during
shuttling of the ubiquitin (Maspero et al., 2011). Only 28 human HECT-type ubiquitin
ligases exist and the vast majority of ligases belong to the RING type.
RING-type Ubiquitin Ligases
Most E3 ligases belong to the RING family. Really Interesting New Gene (RING)
based E3 ligases, originally described in 1991 (Freemont, Hanson, & Trowsdale, 1991)
are encoded by over 600 human genes (human kinases are limited to 518 genes) and
comprise one of the largest enzyme families. RING-type E3 ligases share a common 4060 amino acid RING domain which bind two zinc atoms to zinc-binding “fingers”
(reviewed in (Callis, 2014; Deshaies & Joazeiro, 2009)). RING domains bind E2s and
promote a direct transfer of ubiquitin to substrate. Unlike HECT domain E3 ligases,
RING domain containing ligases do not involve an E3-linked ubiquitin thioester
intermediate. Bi-substrate enzyme RINGs bind the reactants E2~Ub and substrate, in no
precedented order, produce products E2 and substrate~Ub with a Michaelis complex
intermediate. For further ubiquitylation, however, the E2 must be released to allow a
fresh E2~Ub to bind, as E2s cannot be recharged due to the overlapping binding surfaces
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of E1s and E3s. Polyubiquitylation by RING E3s starts with a slow, chain initiation step
followed by a fast, chain elongation step. Unlike conventional bi-substrate enzymes,
which bind both reactants in close proximity to facility the reaction, E3s bind a substrate
and E2~Ub up to 50 Angstroms apart, suggesting conformational changes likely occur to
bring the two reactants closer together for facilitation of the reaction. Ubiquitylation by
RING E3s, like nearly every biological process, is regulated by phosphorylation, through
effects on the substrate, E2, or E3 itself. Substrate phosphorylation is the most common.
Many Cullin-RING ligase substrates such as Skp-1Culin-F-box (SCF) must be modified,
typically by phosphorylation, in order to bind an E3 and undergo ubiquitylation. Others,
such as Anaphase-promoting complex/cyclosome (APC/C)-Cdc20 are activated by
phosphorylation via direct phosphorylation to the E3 allowing tighter binding of the
Cdc20 adaptor. Additionally, binding of APC/ to adaptor Cdh1 during mitosis is
inhibitory as phosphorylated Cdh1 is unable to bind APC/C. Altogether, phosphorylation
is a critical determinant of ubiquitylation promotion.
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Figure 1:4 Cartoon highlighting ligation of ubiquitin to a substrate protein by
HECT or RING E3 ligases. A. HECT E3 ligases form a covalent bond with ubiquitin
and a cysteine within their catalytic domain prior to shuttling ubiquitin to the substrate. B.
Ring E3 ligases bind E2s and promote a direct transfer of ubiquitin to substrate.
Image obtained with permission from work originally published by Kazuhiro Iwai. Trends in Cell Biology.
Diverse ubiquitin signaling in NF-kB activation 2012; 22(7):355 –364.

Ubiquitin Ligase Tripartite Motif-containing Protein 32
Tripartite motif-containing protein 32 (Trim32) is part of the Trim/RBCC protein
super family that contributes to various biological signaling including growth, apoptosis,
cell cycle regulation, muscular physiology, viral and innate immune response, and cancer
(Hatakeyama, 2011; Ikeda & Inoue, 2012). Trim proteins contain the tripartite/RBCC
motif composed of a RING domain, one or two B-box domains, and a coiled-coil domain
(Figure 5) (Meroni, 2012). Trim32 is further subcategorized as a Trim-NHL protein due
to six C-terminal asparagine, histidine, and lysine (NHL) amino acid repeats that function
as protein-protein binding domains (Schwamborn, Berezikov, & Knoblich, 2009). TrimNHL proteins have been shown to regulate expression of microRNAs (miRNA), small
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noncoding RNAs that regulate gene expression post-transcriptionally, and thus ultimately
provide translational control of certain proteins (Loedige & Filipowicz, 2009; Wulczyn,
Cuevas, Franzoni, & Rybak, 2011). Trim32 specifically interacts with AGO1 (via its
NHL domain) and activates miRNA let-7a to promote differentiation in mouse progenitor
cells (Schwamborn et al., 2009).

Figure 1:5 Schematic of Trim32 structure and sites of disease-associated mutation.
RING domain provides E3 ligase function of Trim32. NHL repeats are locations of
protein interaction and microRNA activation. P130S mutation within the BBOX domain
causes BBS, while various mutations with the NHL repeats cause LGMD2A. I
Image adapted with permission from work originally published by Matthew Locke et al. Hum. Mol. Genet.
TRIM32 is an E3 ubiquitin ligase for dysbindin 2009; 18:2344-2358.

Trim32 Ubiquitin Ligase Functionality
The RING domain of Trim32 provides ubiquitin ligase catalysis. Several proteins
have been reported as substrates for Trim32 catalyzed ubiquitylation: Trim32 can
ubiquitylate actin in vitro and decrease endogenous actin in HEK293 cells (Kudryashova,
Kudryashov, Kramerova, & Spencer, 2005), ubiquitylate Abl-interactor 2 (Abi2) in vitro
and promote degradation in HEK293T (Kano, Miyajima, Fukuda, & Hatakeyama, 2008),
bind and promote polyubiquitylation and potential degradation of dysbindin in HEK293
cells (Locke, Tinsley, Benson, & Blake, 2009) and catalyze ubiquitylation of Piasy in
vitro to promote its destabilization and degradation (Albor et al., 2006). All of these
examples show Trim32 is able to catalyze ubiquitylation of particular substrates, either
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directly by using purified recombinant proteins in vitro where Trim32 is the only E3
ligase present, or overexpression in heterologous systems, in both cases monitoring
electrophoretic shifts by Western blot. Tools that can demonstrate ubiquitylation of a
substrate by Trim32 or any E3 ligase directly in tissue are currently limited.
Trim32 Contributes to the Pathology of Human Disease
The ubiquitin system has been implicated in the pathogenesis of many diseases
and genetic disorders. Human neurological disorders appear to be particularly vulnerable
to mutations in ubiquitin ligases (Kessler, 2013). Mutation of the Trim32 gene causes
several disease states. Various point mutations within the NHL repeats D487N (third
NHL repeat), R394H (first NHL repeat), T520TfsX13 (fourth NHL repeat), and D588del
(fifth NHL repeat) are reported to cause LGMD2H (Locke et al., 2009). In addition to
LGMD2H, D487N mutation also causes the more severely debilitating sarcotubular
myopathy (Schoser et al., 2005).
Trim32 in the Adult Brain
Trim32 has been studied primarily with respect to pathologies arising from its
effects in non-neuronal tissue. Although Trim32 is primarily known to cause disease
states with phenotypes localized to skeletal muscle, Kudryashova et al. in 2009 observed
that brain Trim32 exceeds muscle Trim32 by over 100 fold and concluded that Trim32
must have a novel role in the nervous system (Kudryashova, Wu, Havton, & Spencer,
2009). A mutation within the B-box domain (P130S) causes an unrelated disease BardetBiedl Syndrome (Chiang et al., 2006) that has both physical and neurological deficits.
Additionally, increased expression of Trim32 has been reported in the occipital lobe of
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Alzheimer’s disease patients (Yokota et al., 2006), while Trim32 null mice have
abnormal neurofilament accumulation (Kudryashova et al., 2009)- a symptom of various
neurodegenerative diseases (Q. Liu et al., 2004). Finally, Trim32 genetic disruption has
been identified as a risk factor for Autism Spectrum Disorders (ASDs), Attention Deficit
Hyperactive Disorder (ADHD), and other neurodevelopmental disease (Lionel et al.,
2014).
Voltage-gated Potassium Channel 1.2
Membrane Potential of Excitable Cells
Electrical activity of biological organisms is driven, for the most part, by ions.
Living cells are enclosed within a plasma membrane (PM), a semi-permeable lipid
bilayer structure that separates the extra- and intra-cellular space and prevents ions from
freely passing into the cell. The unequal separation of charged ions and other molecules
across the PM generates gradients of both chemical concentration and electrical potential,
collectively referred to as the electrochemical gradient, and a driving force is produced
for the ions to cross the PM. In electrical cells, the difference in electrical potential across
the PM of a quiescent cell, called the resting membrane potential, is driven primarily by
Na+ and K+ ions. At a resting membrane potential, a cell is in a steady state of continuous
passive influx of Na+ and efflux of K+ through resting channels that are counterbalanced
by Na+-K+ pumps utilizing ATP to pump the ions against their respective gradients. The
unequal positive outward flux caused by Na+-K+ pump (3 Na+ out, 2 K+ in/ ATP)
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generates a general hyperpolarization of the PM as the interior is negative relative to the
exterior.
Ion channels embedded within the PM gate the passage of ions across the
membrane. Various factors can trigger the opening of ion channels that allow ions to pass
across the PM down their concentration gradients. In the case of K+, where greater
amounts of K+ reside in the cytoplasm at rest, opening of these channels results in a loss
of positive charge within the cell which increases the negativity of the membrane
potential and hyperpolarizes the cell making it less excitable. Similarly, opening of Na+
channels causes an opposite influx of Na+, increased positive charge, and depolarization
to the membrane. As Na+ influx is a major force for depolarization and generation of
action potentials, K+ efflux counterbalances and limits depolarization.
Overview of Voltage-gated Potassium Channels
Neurons communicate with each other through action potentials (AP) that involve
major alterations in membrane potential. Changes to membrane potential can trigger
opening of certain ion channels, and if a membrane reaches a certain threshold of
depolarization, an action potential is generated whereby voltage-gated sodium (Nav)
channels open to allow the rapid influx of Na+ ions followed quickly by voltage-gated
potassium channels (Kv) opening to allow efflux of K+ and repolarization of the
membrane. Potassium channel opening at the PM drive the membrane potential towards
that of the equilibrium potential of potassium which, in most neurons, causes a
hyperpolarization that oppose excitation. At resting membrane potential, the majority of
Kv channels are closed until a depolarization threshold is reached, which triggers the
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channels to open and repolarize the membrane potential. Thus, some Kv channels return
depolarized cells to resting state following an AP. Some Kv channels, however, are open
at sub-threshold voltages and provide major contribution to the resting membrane
potential.
General Categorization and Structure of Voltage-gated Potassium Channels
Kv channels are divided into subfamilies originally described by genes Drosphila
as Shaker, Shab, Shaw, and Shal and correspond to the alpha subunit classifications of
Kv1, Kv2, Kv3, and Kv4, respectfully in vertebrates (Salkoff et al., 1992). Channels
encoded by Shaker, Shal, Shab, and Shaw express currents with different biophysical
properties. Unlike Drosphila, which has only one member per subfamily, the mammalian
genome contains subfamily genes of Kv channels such as Kv1 which ranges from Kv1.1
to Kv1.12. Structurally, Kv channels are transmembrane channels that tetromerize to
form the functional channel. Kv channels may be homotetramers, and also, in the case of
Kv1, Kv7, and Kv10 families, heterotetramers formed by different alpha subunits within
the same family (with only a few exceptions of different family member tetramerizing)
with their own unique channel properties (reviewed in: (Gutman et al., 2005)).
Additionally, within the same cell, different Kv channels can localize to different cellular
components for specific functionality (Southan & Robertson, 1998). Several Kv1
channels activate at subthreshold voltage in many excitable cells where they can
contribute to the regulation of cell excitability (Bekkers & Delaney, 2001; Dodson,
Barker, & Forsythe, 2002; Shen, Hernandez-Lopez, Tkatch, Held, & Surmeier, 2004).
Kv1.2 is one such channel.
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Overview of Kv1.2 Structure and Function
Kv1.2 provides a major contribution to the resting membrane potential of certain
excitable cells. Kv1.2 channels can be activated at subthreshold potentials, with reported
half activation values ranging from -40mV to +30mV (Rezazadeh, Kurata, Claydon,
Kehl, & Fedida, 2007) and are therefore considered low-voltage-activated channels that
can open at resting potential or by small depolarization (Al-Sabi, Kaza, Dolly, & Wang,
2013). These channels are also rapidly activated.
As with all Kv channel alpha subunits, several functional domains exist within
Kv1.2: the T1 tetramerization domain within the N-terminus, six transmembrane domains
(S1-S6), including the S4 voltage-sensing domain, and a potassium selective pore
between S5 and S6, extracellular domains, and a C-terminus. Both the N and C termini
provide multiple sites for PTM (Mathie, Wooltorton, & Watkins, 1998).
Post-translational Modification Regulates Kv1.2
Like many proteins, Kv1.2 is subject to post-translational modification. N-linked
glycosylation on the first extracellular loop of Kv1.2 is involved in the trafficking of
newly translated Kv1.2 (Shi & Trimmer, 1999; Zhu et al., 2003). Fully maturated Kv1.2
at the PM is subject to phosphorylation. Tyrosine phosphorylation of Kv1.2 suppresses
channel current and causes down regulation (X. Y. Huang, Morielli, & Peralta, 1993).
Current suppression by tyrosine phosphorylation has been shown to occur by channel
endocytosis (Nesti, Everill, & Morielli, 2004). Additionally, serine phosphorylation of
Kv1.2 have also been reported and suggested to impact Kv1.2 surface expression and
trafficking of Kv1.2 (J. W. Yang, Vacher, Park, Clark, & Trimmer, 2007; Connnors et al.,
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2007). It should be noted that post-translational modifications of Kv1.2 could also be
changing channel properties, such as gating, which could in turn alter channel function.
Indeed, this has been shown to occur with many ion channels including Kv1.2 (Huang et
al., 1993), but remains an entirely separate topic of investigation outside the scope of this
work.
Kv1.2 in the Brain
Kv1.2 is abundantly expressed in the nervous system and can be found residing
throughout different critical compartment of a neuron (Dodson et al., 2002; Glazebrook et
al., 2002; Goldberg et al., 2008; Kole, Letzkus, & Stuart, 2007). In dendrites, where
outside information is conveyed into a neuron, Kv1.2 is localized in cerebellar Purkinje
cells (Khavandgar, Walter, Sageser, & Khodakhah, 2005) and hippocampal pyramidal
cells (Sheng, Tsaur, Jan, & Jan, 1994) to oppose dendritic depolarization. Summated
dendritic input can depolarize a neuron to a threshold capable of generating an action
potential, and Kv1.2 in the neuronal soma such as sensory neurons (Andrews & Kunze,
2001) and striatal medium spiny neurons (Shen et al., 2004) can oppose this process as
well. Kv1.2 can also be found Axon Initial Segment that contribute to the generation and
shaping of an AP (Lorincz & Nusser, 2008), as well flanking domains called
juxtaparanode where they modulate axonal excitability by preventing recurrent nodal
excitation (Rasband et al., 1998; Vabnick et al., 1999). Kv1.2 also is found at axonal
branch points in some neurons, particularly inhibitory interneuron basket cells (Tan &
Llano, 1999; Zhang, Messing, & Chiu, 1999). Altogether, Kv1.2 is abundantly expressed
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within the mammalian central nervous system where it can provide regulation of neuronal
excitation.
Exploring Kv1.2 Regulation in the Brain

Kv1.2 regulates neuronal excitability throughout the brain. As with cultured cells,
modulation of Kv1.2 expression in neurons regulate its influence on excitability. For
example, regulation of Kv1.2 in the cerebellum has important consequences for
cerebellar function, affecting not only PC dendritic excitability but cerebellum-dependent
associative learning as well (Williams, Fuchs, Green, & Morielli, 2012). Kv1.2 function
can be modulated by endocytic trafficking triggered by protein-protein interaction in
cultured cells (Hattan, Nesti, Cachero, & Morielli, 2002; Williams, Markey, Doczi, &
Morielli, 2007), however the mechanisms governing Kv1.2 trafficking in the brain
remain largely unknown.
Given the criticality of Kv1.2 in the central nervous system, defining modalities
for Kv1.2 modulation endogenous to the brain may provide valuable insight toward
understanding fundamental neuronal processes. Studies performed in isolated culture
systems have generated the majority of known regulatory mechanisms of Kv1.2 in the
past, however advancements in proteomics allow investigation of proteins in the native
tissue context more plausible. By starting with an unbiased proteomic approach, novel
protein interactions and post-translational modifications of Kv1.2 can be readily detected
from tissue. Such proteomic output can then be further tested in model-systems to
determine mechanisms of Kv1.2 modulation in the brain.
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Summary
The preceding literature review provided background information intended to
supplement the data presented in the manuscripts of Chapters 2 & 3. For both projects,
the conceptual framework was based off initial MS experiments which detected both
PTMs and protein associations with Kv1.2 purified from cerebellar extracts that were
previously unidentified. In Chapter 2, cross-talk between protein ubiquitylation and
phosphorylation was examined in regard to regulation of Kv1.2 by the ubiquitin ligase
Trim32. In Chapter 3, regulation of Kv1.2 by the atypical WNK and closely related
SPAK kinases was investigated. Both studies present potential mechanisms of novel ion
channel and perhaps neuronal excitability regulation in the cerebellum and further
interpretation beyond the manuscripts is explored in the Comprehensive Discussion of
Chapter 4.
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Abstract
Trim32 is ubiquitously expressed throughout the nervous system, however
functional roles for the ubiquitin ligase in the developed brain are not well understood.
Here, using mass spectrometry, we report that Trim32 associates with Kv1.2, an ion
channel critically involved with establishing and maintaining membrane excitability in
neurons. Using immunofluorescence we show that Trim32 co-localizes with Kv1.2 to
regions within the cerebellum. In vitro ubiquitylation assays demonstrated that Trim32 is
catalytically equipped to ubiquitylate Kv1.2. Using co-expression of Kv1.2 and Trim32
in HEK293 cells we show that Trim32 regulates the surface expression of the channel in
cultured cells by two mechanisms, one ubiquitin-dependent and one not. Finally, using a
combination of quantitative mass spectrometry, mutagenesis, and flow cytometry, we
show that the effect of Trim32 on Kv1.2 by both mechanisms involve cross-talk with
Kv1.2 phosphorylation.
Introduction
Protein ubiquitylation is the covalent attachment of the small protein ubiquitin to
a lysine residue within a target protein, either as single units (monoubiquitylation for one
or multiubiquitylation for more than one) or as ubiquitin chains (polyubiquitylation).
Polyubiquitin chains arise by sequential addition of ubiquitin proteins onto a lysine
within ubiquitin, and the specific lysine targeted produces different chains with distinct
biological effects. The most understood role of ubiquitylation involves the generation of
polyubiquitin chains linked at lysine 48 (K48). This type of polyubiquitylation has a
prominent role in targeting proteins for degradation by the 26S proteasome (Ozkaynak,
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Finley, & Varshavsky, 1984). Because the polyubiquitylation-proteasome protein
degradation pathway is by far the most extensively studied, it is not surprising that most
work investigating the role of ubiquitylation in the brain has focused on this pathway
(Artinian et al., 2008; Jarome, Werner, Kwapis, & Helmstetter, 2011; Lopez-Salon et al.,
2001; Reis, Jarome, & Helmstetter, 2013; Rodriguez-Ortiz, Balderas, Saucedo-Alquicira,
Cruz-Castaneda, & Bermudez-Rattoni, 2011). However, recent large-scale proteomic
assessments of the mammalian ubiquitinome have expanded our understanding of both
the magnitude and diversity of ubiquitylation within the brain (W. Kim et al., 2011;
Wagner et al., 2012). Increasingly, evidence indicates that proteasome-independent
effects, mediated by other types of poly, multi, or monoubiquitylation, can function to
regulate membrane proteins in a way that is conceptually similar to phosphorylation
(Haglund et al., 2003; Hicke, 2001; Mosesson & Yarden, 2006). One example is a study
identifying monoubiquitylation of the Inositol 1,4,5-Trisphosphate Receptor (IP3R) which
found eleven sights all within the regulatory domains. The authors proposed locationspecific monoubiquitylation as an essential mechanism for non-proteolytic regulation of
the IP3R (Sliter, Aguiar, Gygi, & Wojcikiewicz, 2011; Sliter et al., 2008).
Enzymatic transfer of ubiquitin to a protein involves the activity of three enzymes
(termed E1-E3), with the E3 (or ubiquitin) ligase conferring substrate specificity
(Hershko et al., 1983). One E3 ligase, Trim32, is highly expressed in mammalian brain
and skeletal muscle (Kudryashova et al., 2009). Most of what is known about Trim32
concerns its role in muscle function and disease. Mutations within Trim32 causes LimbGirdle muscular dystrophy type 2A (LGMD2H) (Frosk et al., 2002) and the more
severely debilitating sarcotubular myopathy (STM) (Schoser et al., 2005). Most reported
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substrates of Trim32 are proteins involved in hereditary skeletal muscle disorders such as
actin and myosin (Kudryashova et al., 2005), desmin (S. Cohen, Zhai, Gygi, & Goldberg,
2012), ABL2 (Kano et al., 2008) and PIASY (Albor et al., 2006). In contrast, despite its
high neuronal expression, Trim32’s molecular targets and roles in the brain are far less
understood. Two recent studies indicate that Trim32 is involved in complex emotional
behavior and may have a role in depression and anxiety disorders (Hillje et al., 2015;
Ruan et al., 2014). Genetic studies have identified links between Trim32 and a range of
neurological disorders, including Autism Spectrum Disorders (ASD) and Attention
Deficit Hyperactive Disorder (ADHD) (Lionel et al., 2014). Intriguingly, ASD and
ADHD linked to Trim32 dysfunction are comorbid with epilepsy, a condition that
involves neuronal hyper-excitability (Lo-Castro & Curatolo, 2014). Mood disorders,
ASD and seizure disorder are associated with defects in neurodevelopment, a process
dependent on Trim32 as a neural stem cell fate determinant (Hillje et al., 2015; Hillje,
Worlitzer, Palm, & Schwamborn, 2011; Schwamborn et al., 2009). Thus, current models
focus on neurodevelopment as a primary mechanism for Trim32 effects in the brain.
However recent studies have identified potassium channelopathies as potential
contributors to ASD as well (reviewed in (Schmunk & Gargus, 2013)).
Voltage-gated ion channels are major determinants of neuronal excitability. The
voltage-gated potassium channel Kv1.2 is expressed widely throughout the nervous
system, but it is expressed to the highest density within the cortex of the cerebellum
(McNamara, Averill, Wilkin, Dolly, & Priestley, 1996; McNamara, Muniz, Wilkin, &
Dolly, 1993; Veh et al., 1995). Its expression there is largely concentrated within
presynaptic terminals that provide inhibitory input to Purkinje cells (Khavandgar et al.,
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2005; Sheng et al., 1994; Southan & Robertson, 1998) and within Purkinje cell dendrites
where it influences responses to excitatory input. Because Purkinje cells form the core
computational unit within the cerebellar cortex, and because they also provide its sole
output to cerebellar nuclei and ultimately the rest of the brain, Kv1.2, through its effect
on Purkinje cells, has a uniquely central impact on cerebellar function. This was recently
underlined by the finding that mutations within Kv1.2 cause a specific type of inherited
cerebellar ataxia (G. Xie et al., 2010).
In this study we identify a new role for Trim32 in the cerebellum as a modulator
of the potassium channel Kv1.2. Using mass spectrometry (MS), we identified Trim32 as
part of the cerebellar Kv1.2 protein interactome and identified sites of ubiquitylation
within native cerebellar Kv1.2. These in vivo findings provided the foundation for in vitro
studies to determine the mechanisms by which Trim32 regulates Kv1.2. We found that
Trim32 mediates mono-ubiquitylation of Kv1.2 which in turn modulates the channels’
endocytic trafficking. Further, we used a quantitative MS approach to show that Trim32
not only affects channel ubiquitylation, but also influences phosphorylation at two Cterminal serines (S434 and S440) that lay adjacent to the channel’s primary ubiquitylation
site (K437), and that phosphorylation at these sites have differential, ubiquitylation
dependent effects on Kv1.2 trafficking. Therefore, our findings indicate that Kv1.2
function is determined by inter-dependent effects of ubiquitylation and phosphorylation.
These findings indicate that Trim32 mediated regulation of Kv1.2 constitutes a potential
novel pathway for the acute regulation of neuronal excitability in the brain.
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Results
The Ubiquitin Ligase Trim32 Co-purifies with Kv1.2 from Rat Cerebellar Extracts

The cell surface level of Kv1.2 is governed by a homeostatic balance between
channel endocytosis from and recycling back to the plasma membrane, a process
controlled by serine/threonine as well as tyrosine phosphorylation of the channel
(Connors, Ballif, & Morielli, 2008; Nesti et al., 2004; Stirling, Williams, & Morielli,
2009). Mechanistic specificity for the regulation of ion channels is conferred to a large
extent by the composition of an associated macromolecular complex of proteins. Such
interactions determine the channel’s sub-cellular localization, but also confer bias
towards regulation by specific signaling pathways (Swayne, Altier, & Zamponi, 2014).
To identify novel interactions of Kv1.2 within the brain, we examined the interactome of
Kv1.2 using an unbiased proteomic approach: Kv1.2 was purified from tissue
homogenates that were separated into non-nuclear membrane fractions prior to lysis.
Kv1.2 and associated proteins were separated by SDS-PAGE electrophoresis, and
separated gel bands were subjected to an in-gel digestion with trypsin to produce tryptic
peptides that were analyzed by liquid chromatography tandem mass spectrometry (LCMS/MS). Figure 1A shows a representative gel stained with Coomassie Blue to indicate
proteins isolated within the appropriate molecular weight range for both Kv1 channels
and Trim32 following Kv1.2 IP. Cerebellum from two rats (6 week old) were lysed in
the presence of protease inhibitors only (HALT cocktail of 100mM AEBSF*HCl, 80µM
Aprotinin, 5mM Bestatin, E-64, 1.5mM EDTA, 2mM Leupeptin, and 1mM Pepstatin A =
MS trial 1), protease inhibitors plus DUB and proteasome inhibitors (HALT protease
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cocktail, 5mM N-Ethylmaleimide, and 10µM MG-132 = MS trial 2), and protease, DUB,
proteasome, and phosphatase inhibitors (HALT protease cocktail, 5mM NEthylmaleimide, and 10µM MG-132, 1mM NaF, 1mM NaOrthovanadate, and 20mM
BAPTA= MS trial 3) yielding 20, 17, and 37 total detected peptides of Kv1.2,
respectively. In all conditions, the ubiquitin ligase Trim32 was detected as a novel
interacting protein by 3 or more unique tryptic peptides that were never present in
parallel, nonspecific IP controls (Figure 1B). This interaction was also detected by
Western blot (WB) analysis, either through IP of Kv1.2 (Figure 1C, left) or Trim32
(Figure 1C, right), both of which demonstrated Co-IP of the interacting partner in the
lysis conditions of MS trial 2 and 3.

Detection of Trim32 from our homogenates was low in the absence of DUB and
proteasome inhibitors, and likewise co-IP was not detected by IP of either Kv1.2 or
Trim32 (Supplementary information; Appendix A Figure A:2), suggesting that
preservation of the association of Trim32 with Kv1.2 may be impacted by enzymes that
alter ubiquitylation.
Trim32 Localizes with Kv1.2 in the Cerebellum
In the brain, Kv1.2 is especially abundant in the cerebellar cortex. The channel is
expressed post-synaptically in the dendrites of Purkinje cells (PC), the major
computational entity within the cerebellum, and pre-synaptically in the axon terminals of
basket cell (BC) interneurons which provide strong inhibitory synaptic input to PCs
(Southan & Robertson, 1998, 2000). Residing within these two key cerebellar locations,
Kv1.2 is able to affect both the inhibition and excitation to PCs, the sole output of the
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cerebellar cortex, and thus influence cerebellar processing to the rest of the brain. Our
immunofluorescence (IF) analysis revealed that Trim32 is ubiquitous throughout the
cerebellum (Figure 2). Co-staining with Parvalbumin, a marker for PCs and molecular
layer interneurons, showed that Trim32 is clearly present in BC soma, cellular origin of
inhibitory complexes called Pinceau which form a basket-like structure around the axon
initiation segment of PCs (Figure 2A and B). Imaging at higher magnification showed
co-localization in the Pinceau more clearly (Figure 2C). In our experiments, Trim32 did
not always overlap with Kv1.2 due to the extensive expression of Trim32 in locations
such as the granule layer and PC somas where Kv1.2 is absent. As a multifunctional
protein enzyme, Trim32 was not expected to exclusively localized with Kv1.2 and these
images are intended to simply provide evidence that Trim32 and Kv1.2 are simple able to
be localized in the cerebellum. Analysis was performed using a Deltavision Restoration
Microscopy System on fixed, permeabilized 50uM thick cerebellar slices and results were
replicated in two separate experiments.
Trim32 can Directly Ubiquitylate Kv1.2 in Vitro
After establishing that Trim32 interacts and localizes with Kv1.2 in the
cerebellum, we next investigated its functional role on the channel. To determine whether
Trim32 can directly ubiquitylate Kv1.2, an in vitro ubiquitylation assay using
recombinant purified GST-fused Trim32 and Kv1.2 variants was performed (Figure 3).
Kv1.2, in the presence of only E1, E2, Trim32 (E3), ATP, and ubiquitin, is ubiquitylated
at either it’s C or N terminus (GST-Kv1.2C/GST-Kv1.2N) by Trim32 as determined by
stepwise ~10kDa molecular weight increases of Kv1.2 (Figure 3B). The reaction was
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initiated by the addition of ATP to activate ubiquitin. As a control, the reaction was also
prevented in an identical experiment by withholding ATP alone and, as expected, no
ubiquitylation was detected. Trim32 self ubiquitylation was additionally used as a
ubiquitylation confirmation (data not shown). To confirm the electrophetic band shifts
were not due to ubiquitylation of GST alone, the reaction was repeated with GST cleaved
Kv1.2C/N and higher molecular weight bandshifts of Kv1.2 were still observed (Figure
3C), indicating that ubiquitylation is occurring on Kv1.2.
Kv1.2 is Ubiquitylated in the Cerebellum
Ubiquitylation of Kv1.2 at two N-terminal lysines (K49 and K63) has recently
been reported by a single, large scale LC-MS/MS study in the mouse brain (Wagner et
al., 2012). No sites of Kv1.2 ubiquitylation have been reported in the cerebellum
specifically. In the same LC-MS/MS experiments that detected the Trim32 interaction
(Figure 1A), we also detected ubiquitylation of Kv1.2 at C-terminal lysine K437 (Figure
4). In particular, two peptides of lysine 437 were detected in each of the three MS trials
(Figure 4C). The previously reported N-terminal lysines were also both detected in one
of three MS trails (Supplementary Information; Appendix C Figure C:2). Given that
Trim32 was the only ubiquitin ligase detected by mass spectrometry from cerebellar
homogenates following Kv1.2 purification, we hypothesize that Trim32 could
ubiquitylate Kv1.2 there.

53

Trim32 Increases Kv1.2 Surface Expression in HEK293 Cells through a Mechanism
Dependent on Channel Ubiquitylation.
Trafficking of Kv1.2 modulates its expression at the surface and therefore overall
impact on membrane potential (Nesti et al., 2004; Stirling et al., 2009). Recently, we have
shown that both BC axon termini and Purkinje cell dendrites are locations of ACdependent Kv1.2 trafficking (Williams et al., 2012). To date, no modulators of Trim32
signaling have been reported, limiting in vivo manipulation. However, heterologous
systems have been valuable tools for investigating Kv1.2 trafficking mechanisms, and
allow the overexpression of mutated constructs that may prevent or cripple the process of
ubiquitylation. We therefore next utilized HEK293 cells to determine if Trim32 can
regulate Kv1.2.
Kv1.2 function is regulated by its endocytosis from and recycling back to the
plasma membrane (Nesti et al., 2004; Stirling et al., 2009). To measure changes in
surface Kv1.2 levels in HEK293 cells we used a flow cytometry assay as previously
described (Nesti et al., 2004). Figures using this assay depict normalized count as the
objective measure in which we interpret as surface Kv1.2. Over-expression of ubiquitin
can drive ubiquitylation of proteins and so we used this method to investigate the effect
of ubiquitin on Kv1.2 trafficking. We used co-expression with wild-type ubiquitin (WTUb) or with a form of ubiquitin that can only induce monoubiquitylation (lysines within
ubiquitin mutated to arginine) of substrates (mUb). WT-Ub caused an overall decrease of
surface channel (-37%, t(df) = 6.65(10), p < 0.0001, n = 6 each) while mUb caused an
increase (+32%, t(d) = 8.27(10), p < 0.0001, n = 6 each) (Figure 5A). We next
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investigated the influence of Trim32 on Kv1.2 surface expression (Figure 5B). Like
mUb, co-expression of wild-type Trim32 caused a significant increase of surface channel
(+15%, t(df) = 4.56(16), p < 0.001, n = 6 (+vector), n = 12 (+Trim32WT)) (Figure 5B,
left graph). In cerebellar tissue, K437 is the most prevalent site of ubiquitylation detected
by multiple LC-MS/MS experiments. We therefore used site directed mutagenesis to
assess the role of this lysine on Trim32 mediated channel regulation. We found that
mutation of K437 to alanine (K437A) caused baseline surface Kv1.2 to decrease
compared to the wild-type channel (-32%, 7.52(16), p < 0.0001, n = 6 (Kv1.2WT), n = 12
(Kv1.2K437A). Strikingly, this point mutation eliminated the surface Kv1.2 increase seen
with Trim32 co-expression +0.004%, t(df) = 0.17(22), p = 0.87, n = 12 each). Taken
together, overexpression of Trim32 appears to cause a significant increase of surface
Kv1.2 through a mechanism that may involve mono-ubiquitylation at lysine 437, the
most prevalent site of ubiquitylation detected in cerebellar tissue.
To determine whether over-expression of Trim32 or mUb involves modification of other
lysine residues within Kv1.2, we assessed their effect on mutant forms of Kv1.2 that have
all C and N terminal lysines replaced with arginine (Kv1.2KR). Kv1.2KR dramatically
attenuated the Trim32 and mUb effects on Kv1.2 trafficking: 2-way ANOVA significant
main effect of co-expressions (column); F(2, 105) = 52.50, p < 0.0001, and a significant
main effect of Kv1.2 lysines (row), F(1, 102) = 125.2, p < 0.0001, n = 12 (Kv1.2WT+
vector), n = 24 (Kv1.2WT + Trim32), n = 18 (Kv1.2WT + mUb), n = 12 Kv1.2KR, n =
24 (Kv1.2KR + Trim32), n = 12 (Kv1.2KR + mUb). To test whether the effect of Trim32
on Kv1.2 was dependent on the ubiquitin ligase activity of Trim32 we used a version of
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Trim32 lacking its catalytic RING domain (Trim32∆RING). In duplicate experiments we
found that this version of Trim32 had no effect on Kv1.2 (Figure 5D):1-way ANOVA,
F(3, 44) = 188.2, p < 0.0001; Kv1.2WT + Trim32WT-Flag (+100%, q(df) = 13.82(44), p
< 0.0001, n = 12 each), Kv1.2WT + Trim32WT-GFP (+133%, q(df) = 18.40(44), p <
0.0001, n = 12 each), Kv1.2WT + Trim32∆RING (-5.32%, q(df) = 0.7341(44), p > 0.05,
n = 12 each. Collectively, these results suggest that Trim32 is able to increase Kv1.2 at
the cell surface through channel monoubiquitylation.
As indicated in Figure 3, attachment of the small protein ubiquitin to a substrate
adds a molecular weight increase (~8.5kDa without FLAG tag) that can be detected
through electrophoretic bandshifts via immunoblot analysis. We therefore used WB
analysis to determine whether overexpression of either Trim32 or mUb causes detectable
changes in the electrophoretic mobility of Kv1.2 expressed in HEK cells (Figure 5E).
Overexpression of Kv1.2 in HEK cells produces two main bands representing different
glycosylation states of the channels development (lower = high mannose and higher =
mature). In the presence of either Trim32WT or mUb, two clear bands of approximately
8.5kDa increased molecular weight from the high mannose Kv1.2 appear that is only
faintly detected in the Kv1.2 only (+ empty vector) transfection (Figure 5B). Total Kv1.2
had no significant change in three replicate experiments (data not shown). Taken together
with the flow cytometry data, Trim32 is able to cause detectable monoubiquitylation that
causes a functional change in Kv1.2 expressed at the cell surface that is independent of
degradation.
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Trim32 Decreases Kv1.2 Surface Expression Independent of Ubiquitylation of
Kv1.2
During the course of this study we observed that the confluence of plated cells
dramatically impacted the effect of Trim32 on Kv1.2 surface expression. In other
contexts, Trim32 has been shown to have ubiquitin-independent effects, the most
understood being the binding of proteins to its NHL repeats for activation of microRNAs
(Loedige & Filipowicz, 2009; Wulczyn et al., 2011). We therefore asked if the
confluence-dependent effects that we observed on Kv1.2 might involve ubiquitinindependent mechanisms. In the following experiments, we utilized cells grown to higher
confluence (plated at higher density and grown one additional day) simply as a
representation of a different cellular condition that may demonstrate different signaling
patterns than that of the lower confluence conditions of the previous experiments. We
found that in highly confluent cells, Trim32 caused a significant decrease of surface
Kv1.2 (-32%, t(df) = 8.30(60), p < 0.0001, n = 12 (Kv1.2WT + vector), n = 6 (Kv1.2 +
Trim32) (Figure 6A, left). MUb, however, continued to cause a significant increase in
surface Kv1.2 (+18%, t(df) = 4.72(60). As expected, replacing Kv1.2WT with Kv1.2KR
diminished the Kv1.2 surface increase by mUb (+3.7%, t(df) = 1.20(60), p > 0.05, n = 12
(Kv1.2KR + vector), n = 12 (Kv1.2 + mUb) however, unlike cells plated at low
confluence, the effect of Trim32 was unchanged in Kv1.2KR channels (-37%, t(df) =
11.86(60), p < 0.0001, n = 12 each; mean difference between rows (Kv1.2WT vs
Kv1.2KR) = 5.29%, p > 0.05; two-way ANOVA significant lysine effect, F(1, 60) =
11.24, p < 0.0025, significant co-expression factor F(2, 60) = 196.2, p < 0.0001, n = 12
(Kv1.2WT + vector), n = 6 (Kv1.2 + Trim32), n = 12 (Kv1.2WT + mUb), n =
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12(Kv1.2KR + vector), n = 12 (Kv1.2KR + Trim32), n = 12 (Kv1.2KR + mUb). This
effect was enhanced by replacing Trim32WT with Trim32∆RING (mean difference
between Kv1.2WT+ GFP-Trim32WT vs Kv1.2WT + GFP-Trim32∆RING = -39%, p <
0.0001), lending strong support for this being a ubiquitin-independent effect of Trim32
on Kv1.2 (Figure 6A, right).
Recent studies have shown that ubiquitylation and phosphorylation can have
substantial cross talk. Phosphorylation can promote or inhibit ubiquitylation leading to or
altering various signaling events (reviewed in (Hunter, 2007)). Additionally, ubiquitin
ligases can be activated by phosphorylation, and similarly, kinases can be deactivated by
ubiquitylation (Persaud et al., 2014; Snyder, 2009). We wondered if the presence of
Trim32 can influence the phosphorylation state of Kv1.2 during high confluence
conditions. To investigate this, we used the quantitative LC-MS/MS method of Stable
Isotope Labeling of Cells in Culture (SILAC) to detect quantitative changes of
phosphorylation following co-expression with Trim32. Kv1.2 was expressed alone
(+empty vector) in cells cultured in media containing arginine and lysine amino acids
with light isotopes (K 12C6 & 14N2 and R 12C6 & 14N4), while Kv1.2 was co-expressed
with Trim32 in cells cultured in media containing arginine and lysine amino acids with
heavy isotopes (K 13C6 & 15N2 and R 13C6 & 145N4 (Figure 6B). Cells were lysed in buffer
conditions equivalent to tissue MS trial 3 of Figure 1 and equal protein concentration
from both light and heavy populations were pooled together prior to electrophoresis.
Lysates were immunoprecipitated for Kv1.2 and processed for LC-MS/MS exactly as the
cerebellar homogenates with the addition of reduction (.1M DTT, 30min, 55 degrees C)
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and alkylation (55mM, 45 minutes RT) iodoacetamide) prior to digestion for proper
quantification of cysteine containing peptides.
In agreement with the flow cytometry experiments, no ubiquitylated peptides of
Kv1.2 were detected in ether the absence or presence of Trim32 in the highly confluent
cells. Because Kv1.2 is highly phosphorylated at several serine residues adjacent to the
cerebellar ubiquiylation site K437, we examined whether Trim32 overexpression alters
these states of phosphorylation. Interestingly, the presence of Trim32 caused a dramatic
decrease of phosphorylated S434 with a corresponding increase of the nonphosphorylated S434 peptide (at both +2 (Figure 6C, top) and +3 (not shown) charge
states), while S440 was unchanged (Figure 6C, bottom). It should be noted that the
nonphoshorylated peptides of 1048.98 (light) and (1052.99 heavy) m/z were confirmed
by MS2 fragmentation, however the detected peptides reported here of 1089.00 and
1093.01 m/z as the phosphorylated versions were not given their overall low abundance
in the MS1 process and the non-targeted LC-MS/MS approach performed. The peptide
m/z was in agreement with previous reports of the same peptide (Yang et al., 2007) as
well as previous LC elution retention times previously detected by our lab (data not
shown). In all of our experiments in tissue and cultured cells, this phosphopeptide was
always localized to S434 and not nearby T433.
Like K437 ubiquitylation, S434 and S440 phosphorylation are consistently
detected in cerebellar tissue. We investigated if these modification sites, like K437, have
a role in surface trafficking of the channel in HEK cells. To avoid compensation by
nearby T433 and S441 (and account for potential ambiguity of LC-MS/MS spectra
matching), we compared Kv1.2WT to Kv1.2T433V/S434A and Kv1.2S440A/S441A
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double mutants. In cells plated to low confluence, Kv1.2T433V/S434A mutation caused a
dramatic reduction in surface Kv1.2 (-80%, q(df) = 17.92(47), p < 0.0001, n = 6 each).
Kv1.2S440A/S441A had a more subtle but significant decrease of surface Kv1.2
compared to the wild-type channel alone (-14%, q(df) = 3.25(47), p < 0.001, n = 6 each)
that was not significant by individual t-test. These results suggest that availability of S434
(and possibly T433) for phosphorylation may be critical for getting Kv1.2 to the surface
(the functional role of S434 is unknown). Additionally, adding Trim32 overexpression,
we see the expected increase of surface Kv1.2, however Kv1.2T433V/S434A amplified
the effect by 10 fold (mean difference between Kv1.2WT + Trim32 and
Kv1.2T433/VS434A + Trim32 by 1-way ANOVA multiple comparisons = 151.12%, p <
0.0001) (Figure 6D, left and middle insert). Unexpectedly, the Kv1.2S440A/S441A
mutant, which caused a modest decrease of surface Kv1.2 alone, reversed the effect of
Trim32 to a significant decrease, suggesting that the increase of Kv1.2 surface expression
by Trim32 may first require phosphorylation of S440/S441.
Discussion
Although historically viewed as a regulator of motor function, a growing body of
research indicates the cerebellum is essential for a wide range of non-motor functions.
These include modulation of autonomic function to processing of emotional information
and other cognitive functions. The link to emotional and cognitive function may be
especially important for understanding behavioral and cognitive symptoms of autism
since defects in cerebellar structure are highly correlated with autism (Allen, Muller, &
Courchesne, 2004; Fatemi et al., 2012; Whitney, Kemper, Bauman, Rosene, & Blatt,
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2008). Interestingly, ASD is not typically associated with motor dysfunction, suggesting
a particularly important role for non-motor cerebellar effects. Genetics studies suggest a
key role for disruption in cerebellar inhibitory neurotransmission, but the
neurophysiological mechanisms linking cerebellar function with ASD remain unclear.
Understanding the neurophysiological roles of autism-related genes, such as Trim32, is
therefore essential.
Trim proteins are involved in diverse biological processes throughout the body,
and Trim32 is no exception. The links of Trim32 mutation to degenerative muscular
disease led to the magnitude of discovered Trim32 functions within skeletal muscle
tissue, however more Trim32 resides within the brain than all other organs combined,
suggesting that Trim32 likely has important neurological roles that are at this time,
overlooked (Kudryashova et al., 2009). The work in this study proposes a unique and
exciting role for Trim32 in the adult brain: From purified cerebellar tissue, we first took
an unbiased proteomic approach to identify Trim32 as an interacting protein with Kv1.2,
an ion channel key for regulating neuronal excitability. Next, we used mutagenesis and
overexpression across both biochemistry and flow cytometry experiments to provide
evidence that Trim32 regulates Kv1.2’s surface trafficking through multiple mechanisms.
Trim32’s most understood role is its ubiquitin ligase activity, particularly in
catalyzing polyubiquitin chains on proteins to signal their degradation by the proteasome.
Here, we have shown that Trim32 can regulate Kv1.2 in a ubiquitin-dependent but
degradation-independent mechanisms. In heterologous systems, our data suggest that
Trim32 increases channel surface expression by a monoubiquitlyation like mechanism.
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Comparing Trim32 overexpression experiments (both biochemistry and flow cytometry)
with those of wtUb and mUb, the increased surface Kv1.2 appears to work through mono
or multiubiquitylation of the channel. Non-degradative trafficking of ion channels by
mono or multiubiquitylation has been previously reported, however, usually the ubiquitin
tagged channels are endocytosed into primary vesicles and trafficked to early endosomes
where ubiquitin is removed by deubiqitinating enzymes (W. H. Wang, 2006).
Monoubiquitylation of ROMK1 (Kir1.1) decreases its surface but not total expression
(Lin et al., 2005), while overexpression of an E3 ligase (Nedd4-2) also caused decreased
surface Kv1.3 and Kv1.5 in Xenopus Oocytes (Boehmer et al., 2008; Henke, Maier,
Wallisch, Boehmer, & Lang, 2004). Monoubiquitylation is recognized as a sorting signal
throughout the endocytic pathway, however a mechanism to promote expression at the
plasma membrane through endocytic trafficking, perhaps by increased recycling, has not
been reported. Our finding that Trim32 increases surface Kv1.2 is consistent with such a
mechanism although other mechanisms, including decreased constitutive endocytosis or
increased biosynthetic trafficking to the plasma membrane are also possible.
How Trim32 affects Kv1.2 in vivo and what the effects of that are on brain
function remains unknown. As mentioned previously, large-scale genetic reports have
determined Trim32 is both a risk factor for ASD/ADHD as well as a genetic link for
ASD/ADHD comorbid with epilepsy, a disease state with known Kv1 channel
involvement. A point mutation in Trim32s B-Box domain (P130S) leads to the less
commonly developed Bardet-Biedl Syndrome (Chiang et al., 2006) that, interestingly,
some patients with Bardet-Biedl syndrome report cerebellar dysfunction (Keppler62

Noreuil et al., 2011), including a case of cerebellar ataxia (Kowal & Sikora, 1989), a
channelopethy that can be caused by KCNA2 (Kv1.2) mutation (G. Xie et al., 2010). The
findings reported here linking Trim32 with Kv1.2 function suggests novel avenues for the
development of therapeutics and pharmaceuticals for these diseases.
Materials and Methods
Tissue Harvest and Membrane Fractionation
Cerebellar tissue was harvested from adult (5-9 week) Sprague Dawly rats and
homogenized in 10 mM HEPES (pH 7.4), 0.3M sucrose, 2mM EDTA, 1mM DTT, 1mM
NaF, 1mM NaOrthovanadate, 20mM BAPTA, 5mM NEM, 10 µM MG-132 and protease
inhibitors (HALT cocktail of 100mM AEBSF*HCl, 80µM Aprotinin, 5mM Bestatin, E64, 1.5mM EDTA, 2mM Leupeptin, and 1mM Pepstatin A) using a 15mL dounce
homogenizer (10-15 strokes). Nuclear proteins were removed by low speed spin (1000g
for 10 min at 4°C) and samples were separated into membrane fractions by
ultracentrifugation (200,000 for 90 min at 4°C). The supernatant containing cytosolic
proteins was discarded and remaining non-nuclear, membrane fraction was then resuspended and lysed in 50mM Tris (pH 7.41), 150 mM NaCl, 1mM EDTA, 0.25%
deoxycholate, 1% NP-40, 1mM DTT, 1mM NaF, 1mM NaOrthovanadate, 20mM
BAPTA, 5mM NEM, 10 µM MG-132 and protease inhibitors (HALT).
Co-immunoprecipitation
Immunoprecipitation (IP) with soluble lysates was performed with magnetic Dynabeads
(Gibco, 30µl bead/ 1µg antibody) for 1 hr at 4°C. IPs were washed three times with lysis
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buffer. Lysates and IPs were analyzed by SDS-PAGE and Western blotting using antiKv1.2 (K14/16 mouse monocolonal, UC Davis, 1.5µg/cerebellum) and anti-Trim32
(Rabbit polyclonal, GeneTex, 1.5µg/cerebellum) antibodies. For IPs processed for LCMS/MS analysis, proteins were separated by 1D SDS-PAGE electrophoresis and
visualized with Coomassie staining.
In Gel Digestion and Mass Spectrometry Analysis
Coomassie stained gel pieces were excised, diced, washed, destained, dehydrated, and
digested with 1.25ng/µl trypsin as previously described (Connors et al., 2008) Extracted
peptides were analyzed by LC-MS/MS using an LTQ linear ion trap mass spectrometer
alone or as a LTQ-Orbitrap hybrid mass spectrometer (SILAC). Identification of posttranslational modifications included dynamic modification of 79.96 to S/T/Y and
114.0429 to K amino acids. A detailed description of mass spectrometric conditions are
presented in the Extended Experimental Procedures.
Immunofluorescence
Cerebellar/hippocampal slice images: Adult rat cerebellar slices (50 µM) were fixed (2%
formaldehyde cardiac perfusion), permeabilized (0.2% Triton X-100), blocked, and
stained for Kv1.2 (1:200) and Trim32 (1:100), and imaged using a DeltaVision
Restoration Microscopy System (Applied Precision). Images were acquired 20X, 60X, or
100X oil immersion lenses using the SoftWorks software and analyzed with NIH Image
J. Colocalization was determine using the Colocalization Point plugin using automated
threshold detection that was manually verified.
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In Vitro Ubiquitylation Assay
Purified recombinant FLAG-ubiquitin, ubiquitin-activating enzyme (E1), and E2
ubiquitin-conjugating enzymes (UbcH5a) were purchased from Boston Biochemical.
GST-Trim32 was expressed in E. coliBL21(DE3)pLysS strain (Stratagene), and isolated
from cells lysed in 10 mMTris/HCl, pH 8.0, 10% glycerol, 1% Triton X-100, 100 mM
NaCl, 10 mM MgCl2, 10 µM ZnCl2, and protease inhibitors using glutathione-Sepharose
4B beads in bulk suspension. Prior to use, Trim32 was released from the GST-bead
complex with thrombin in buffer containing 50 mM Tris, 5 mM MgCl2, 100 mM NaCl, 1
mM DTT and 0.5. In vitro ubiquitination reactions were done by combining FLAGubiquitin, E1 and E2 (UbcH5a) ligase, ATP and Trim32 in 50 mM Tris/HCl, pH 8.0, 5
mM MgCl2, and 0.5 mM dithiothreitol. Reactions were incubated at 37 °C for 120 min
and stopped by heating to 100 °C in protein sample buffer.
Cell Culture and Flow Cytometry
Kv1.2 was overexpressed in HEK293 cells stably expressing the beta subunit HEKβ2.
For detection of cellular surface expression, an antibody that binds an external portion of
Kv1.2 was used for fluorescent detection by flow cytometry as previously described
(source). For high confluence detection, cells were allowed to grow for an additional 1-2
days following transfection.
SILAC Mass Spectrometry
Culture media in the Light population contained lysine and arginine amino acids with K
= 12C6 & 14N2 and R = 12C6 & 14N4) while Heavy populations contained them with K =
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C6 & 15N2 and R 13C6 & 15N4. Cells were grown to full confluence and split 5 times in

respective media before plating for transfection. In repeat experiments, the Light
population was overexpressed with Kv1.2 + empty vector and the Heavy population with
Kv1.2 + Trim32.

Supplementary Materials
Supplementary material can be found in Appendix A.
Figure Legends
Figure 1. The ubiquitin ligase Trim32 interacts with Kv1.2 in the cerebellum. A.)
Coomassie stained gel showing successful immunoprecipitation of proteins in the
predicted range of neuronal Kv1 channels (~90kDa) and Trim32 (65-100kDa). B.)
Trim32 can be detected by LC-MS/MS after immunoprecipitation of Kv1.2 from rat
cerebellum tissue. Throughout multiple experiments, no Trim32 peptides were detected
in parallel IgG antibody control IPs. C.) The Trim32 interaction with Kv1.2 in cerebellar
tissue can also be detected by Western blot co-IP analysis. Left: WBs showing IP of
Kv1.2 (top) with corresponding Trim32 Co-IP (middle) and lysate (bottom) confirming
both proteins.

Figure 2 Trim32 is expressed in cerebellar localizations with Kv1.2. A.) Cartoon
depiction of cells within the cerebellum and localizations of Kv1.2. B.) Trim32 is diffuse
throughout the cerebellum as examined immunofluorescence at 10X magnification (data
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not shown). Closer examination (60X) with co-staining of Parvalbumin (yellow), a
marker for molecular layer neurons and PCs, show Trim32 is found within BCs. C.)
Kv1.2 is of highest expression in BC pinceaus structures, and high magnification (100X)
show Trim32 also localizes to these structures.

Figure 3. Trim32 can directly ubiquitylate Kv1.2 in vitro. A.) Schematic image of the
in vitro ubiquitylation reaction. Recombinant purified E1, E2 and Trim32 (E3) proteins
were combined with a recombinant purified GST-fusion protein of the C or N-terminus
of Kv1.2 (GST-Kv1.2N/C). The ubiquitylation reaction was initiated by addition of ATP.
B.) Immunoblot analysis shows incremental upward shifts in electrophoretic mobility of
GST-Kv1.2N/C indicative of the increased molecular weight conferred by covalent
attachment of ubiquitin. These shifts are absent in reactions lacking ATP. C.) Repeat
experiment with Kv1.2C after GST cleavage showing increased electrophoretic band
shifts that overlap in both Flag (ubiquitin) and Kv1.2 channels.

Figure 4. Kv1.2 is ubiquitylated in the rat cerebellum. LC-MS/MS output of Kv1.2
K437 ubiquitylation showing liquid chromatography elution peaks (top insert),
representative MS1 detection of tryptic peptide at m/z 1064.54 (top), and second MS
fragmentation spectrum (bottom). Table insert lists the Sequest XCorr values for the
peptides detected, all at charge state +3.
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Figure 5. Trim32 increases Kv1.2 surface expression through ubiquitylation. Flow
cytometry was used to monitor Kv1.2 surface expression by whole cell fluorescent
detection after incubation with an external loop tagged Kv1.2 antibody. A.) Cotransfection with wild type ubiquitin (WT-Ub) causes a significant decrease in surface
Kv1.2, while co-transfection with a form of ubiquitin that cannot form chains (mUb),
causes an increase in surface Kv1.2. B.) Like mUb, overexpression of Trim32 also
caused increased surface Kv1.2, an effect that was attenuated by single point mutation of
K437 (the prominent site of cerebellar ubiquitylation). C.) In cells plated to low
confluence, Trim32 repeatedly caused a significant increase of surface Kv1.2, an effect
that is dependent on Kv1.2 lysines shown by replacement of Kv1.2WT with Kv1.2KR.
D.) Mutation of Trim32’s ubiquitylation catalytic RING domain, like Kv1.2KR,
diminished the increase of surface Kv1.2 after Trim32 coexpression. E.) Using WB
analysis, co-expression of Trim32 (middle lane compared to left lane) appears to cause
monoubiquitylation bandshifts (~8.5kDa) of Kv1.2 similarly to monoUb (right lane
compared to left lane). Taken together, Trim32 appears to cause an increase in surface
Kv1.2 through a mechanism involving monoubiquitylation of the channel. * = p <0.05 **
= p <0.01*** = p <0.001 by students’ t-test or two-way ANOVA. Sample size (n) for
each experiment or combined experiments are listed inside the bar graphs.

Figure 6. Trim32 lowers surface Kv1.2 independent of ubiquitylation. A.) The
transient transfections of Figure 5C and D were repeated using HEK293 cells that were
plated and grown to high confluence and flow cytometry assessment demonstrated that
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under these conditions, Trim32 causes a significant decrease of surface Kv1.2 that is
independent of both Kv1.2 lysines and Trim32 ubiquitin ligase activity. B.) Stable
Isotope Labeling of Cells in Culture (SILAC) was used to quantitatively examine whether
co-expression of Kv1.2 with Trim32 can alter Kv1.2’s phosphorylation state in highly
confluent cells. In the light population, Kv1.2 was co-transfected with empty vector,
while in the heavy population Kv1.2 was co-transfected with Trim32, and the relative
change in the MS1 intensity spectra in the light vs. heavy fractions provided a
quantitative measure of Trim32’s effect on Kv1.2 phosphopeptide abundance. C.) We
find, in repeated experiments, that Trim32 strongly decreases phosphorylation of serine
434 within Kv1.2 (C, top), but has no effect on another prevalent phosphorylation site
serine 440 within the channel (C, bottom). The functional role of S434 phosphorylation
remains to be elucidated. Using flow cytometry with T433V/S434A and S440A/S441A
double mutants, we found the S434 but not S440 double mutant caused a dramatic
decrease in surface Kv1.2, which facilitates Trim32’s surface Kv1.2 increasing
mechanism (D, left and insert). Co-expression of Trim32 with S440A/S441A now caused
surface Kv1.2 to significantly decrease. Double mutants were used to avoid MS2
ambiguity potential phosphorylation compensation.* = p <0.05 ** = p <0.01*** = p
<0.001 by students’t-test or two-way ANOVA. Sample size (n) for each experiment or
combined experiments are listed inside the bar graphs. Heavy and Light SILAC peaks
were extracted under equal LC elution peaks, and MS peaks were averaged across
multiple peaks where statistical analysis was used to determine significance between
relative intensities.
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Figure 7. Proposed model for Trim32 induced regulation of Kv1.2. The following
model of surface Kv1.2 regulation by Trim32 is proposed: Under certain cellular
conditions (low confluence in HEK293 cells), Trim32, through its E3 ligase RING
domain, catalysis ubiquitylation of Kv1.2 at lysine 437 in coordination with S440/S441
phosphorylation to promote Kv1.2 at the plasma membrane. Under different cellular
conditions (high confluence in HEK293 cells), Trim32, independent of its RING domain,
facilitates the removal of S434 phosphorylation to promote internalization of Kv1.2 from
the plasma membrane.
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Figures

Figure 2:1 Ubiquitin ligase Trim32 interacts with Kv1.2 in cerebellar extracts.
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Figure 2:2 Trim32 is expressed in cerebellar localizations with Kv1.2.
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Figure 2:3 Trim32 can directly ubiquitylate Kv1.2 in vitro.
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Figure 2:4 Kv1.2 is ubiquitylated at K437 in the cerebellum.
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Figure 2:5 Trim32 increases Kv1.2 surface expression through ubiquitylation.
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Figure 2:6 Trim32 lowers surface Kv1.2 independent of ubiquitylation.
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Figure 2:7 Model of Trim32 induced trafficking of Kv1.2.
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Abstract
WNKs are a family of serine/threonine kinases widely expressed in the brain
where they are associated with several neurological disorders, including autism and
schizophrenia. They have been most extensively studied in kidney where they regulate
cation-chloride cotransporters. In the brain, WNK1 and its downstream target SPAK also
regulate cation-chloride co-transporters, and are hypothesized to influence chloride
homeostasis during inhibitory neurotransmission. Here we report that in the cerebellum
WNK1 and SPAK complex with and regulate the voltage-gated potassium channel
Kv1.2, indicating a new mechanism for WNK-SPAK signaling and identifying a novel
cellular pathway for regulating neuronal excitability. Using mass spectrometry and
immunoblot, we identified WNK1 and SPAK as components of the cerebellar Kv1.2
protein interactome. Immunofluorescence studies revealed that WNK1 is expressed,
along with Kv1.2, in cerebellar Purkinje cells. Kv1.2 function is regulated by its
endocytic trafficking to and from the cell surface, and flow cytometry analysis of surface
Kv1.2 in HEK293 cells showed that both WNK1 and SPAK influence Kv1.2 expression
at the cell surface. In the presence of functional SPAK, WNK1 over-expression reduced
surface Kv1.2 as did over-expression of SPAK. In contrast, WNK1 increases surface
Kv1.2 levels when uncoupled from SPAK using either the pharmacological inhibitor
STOCK-1S50669 or expression of a version of SPAK lacking the phosphorylation site
required for its activation by WNK1. Evidence that the interaction between WNK1 and
Kv1.2 is regulated in vivo comes from our finding that significantly less WNK1 co85

immunoprecipitated with Kv1.2 of rats that had been subject to eye-blink conditioning, a
type of cerebellar learning that we have previously shown to be influenced by Kv1.2
regulation. We conclude that WNK1/SPAK regulation of Kv1.2 is a novel cellular
mechanism governing cerebellar function.
Introduction
Mammalian with-no-lysine [K] (WNK) are a class of serine-threonine protein
kinases that detect changes in intracellular chloride concentration [(Cl-)i]. In the kidney,
where WNK signaling is the most studied, WNKs have been shown to both govern the
kinase-regulation of ion transport and contribute to the development of inherited and
acquired forms of salt-sensitive hypertension (for review, see (Hoorn & Ellison, 2012)).
All four WNK kinase isotypes are found in the brain (Holden, Cox, & Raymond, 2004;
Kahle et al., 2004; O'Reilly, Marshall, Speirs, & Brown, 2003; Rinehart et al., 2011;
Verissimo & Jordan, 2001), although WNK1 and WNK2 are the most abundantly
expressed. Despite their widespread expression in the brain, comparatively little is known
about their function there (Delaloy et al., 2006; Rinehart et al., 2011).
Most studies indicate that WNKs are the chloride sensing unit of a cascade of
kinases that ultimately control intracellular ion homeostasis. Immediately downstream of
WNK kinases are two structurally similar kinases: oxidative stress-responsive kinase 1
(OSR1) and STE20/SPS1-related proline/alanine-rich kinase (SPAK), both of which are
phosphorylated and consequently activated by WNKs (Welling, Chang, Delpire, &
Wade, 2010). SPAK and OSR1 in turn phosphorylate cation-chloride co-transporters,
regulating their activity (Dowd & Forbush, 2003; Gagnon, England, & Delpire, 2006;
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Piechotta, Lu, & Delpire, 2002). In the adult brain, these transporters consist mainly of
the Na+-K+-2Cl- co-transporter NKCC1,which drive chloride influx, and the K+-Cl- cotransporter KCC2 which drive efflux of intracellular chloride (de Los Heros et al., 2014).
The main inhibitory neurotransmitters in the brain are gamma-amino butyric acid
(GABA) and glycine, both of which activate ligand gated chloride channels. Thus,
WNK/SPAK regulation of cation-chloride co-transporters has a major influence on
excitability in the brain. Mutation or alteration of SPAK/OSR1 are correlated with
increased neuronal activity leading to epilepsy (reviewed in (Alessi et al., 2014)), while
defects in KCC2 are also implicated in disease state involving hyper-excitability and
deficits in GABAA receptor mediated neuronal inhibition (Silayeva et al., 2015).
Additionally, models of acquired epilepsy show elevated SPAK expression in
hippocampal neurons (L. Yang et al., 2013).
WNK and SPAK induced trafficking of cation-chloride co-transporters is well
defined, particularly in the kidneys. Recent studies, however, have shown that SPAK is
also able to affect trafficking other types of membrane proteins (Elvira et al., 2014;
Elvira, Warsi, Munoz, & Lang, 2015; Fezai et al., 2014; Warsi et al., 2014). One target,
chloride channel protein 2 (ClC-2), is a voltage -and chloride-sensitive channel that
contributes to the regulation of neuronal excitability (Foldy, Lee, Morgan, & Soltesz,
2010; Ratte & Prescott, 2011; Rinke, Artmann, & Stein, 2010; Warsi et al., 2014). In
inhibitory basket cells of the hippocampus, ClC-2 was demonstrated to extrude Cl- under
intense neural firing to maintain efficacy of GABAergic inhibition (Foldy et al., 2010).
Other studies have proposed that under physiological conditions, ClC-2 channels permit
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Cl- entry into the neurons to reduce neuronal excitability (Ratte & Prescott, 2011).
Recently, overexpression of SPAK kinase was shown to modulate Kv1.5 surface levels in
a Xenopus oocyte expression system (Elvira et al., 2015). This finding is particularly
interesting because it suggests roles for WNK/ SPAK that extends beyond their direct
effects on chloride homeostasis.
Voltage-gated potassium channels are expressed throughout the brain and have
diverse electrophysiological effects. In the cerebellum, Kv1 family of voltage-gated
potassium channels, in particular those harboring the Kv1.2 alpha subunit, contribute to
excitability of Purkinje cells (PC), the main computational unit and sole output of the
cerebellar cortex (Southan & Robertson, 1998, 2000). In a previous study we showed
that suppression of Kv1.2 by the neuromodulator secretin increases dendritic excitability
of PCs. We also reported that such suppression of Kv1.2 enhanced cerebellum-dependent
eye blink conditioning (EBC). Thus, the regulation of Kv1.2 impacts core
neurophysiological and computational functionalities of the cerebellum, including those
governing behavior. (Williams et al., 2012). In this study, we identified WNK1 and
SPAK kinases as components of the cerebellar Kv1.2 interactome, suggesting a new
mechanism for regulating excitability in the brain. We report that WNK1 is present in
cerebellar Purkinje cells along with Kv1.2. Using a cell culture system we show that
both kinases can regulate Kv1.2 expression at the cell surface. Finally, we demonstrate
that the physical association between WNK1 and Kv1.2 decreased in cerebellum from
rats trained in an associative conditioning task, suggesting that WNK1 regulation of
Kv1.2 contributes to higher order functions in the brain.
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Materials and Methods
Materials
Antibodies: The following primary antibodies were used in this study: Flow Cytometry: A
rabbit polyclonal antibody directed against the first extracellular loop of Kv1.2 (αKv1.2e) developed in conjunction with BioSource International (Camarillo, CA)”
(Stirling et al., 2009), Immunoprecipitation, immunofluorescence, and immunoblotting:
mouse monoclonal Kv1.2 (K14/16; Neuromab) rabbit polyclonal C-terminal WNK1
(GTX30695; GeneTex), rabbit polyclonal SPAK (2281S; Cell Signaling), rabbit
polyclonal SPAK (Pierce, PA5-17338), and rabbit polyclonal GAPDH (ab9485; Abcam).
The following secondary antibodies were used in this study: Immunofluorescence: Goat
anti-mouse Alexa Fluor 488 (Invitrogen), Goat anti-rabbit Alexa Fluor 568 (Invitrogen),
Goat anti-rabbit Alexa Fluor 647 (Invitrogen); Immunoblotting: Goat anti-mouse 700
(Invitrogen), Goat anti-mouse 800 (Rockland); Flow Cytometry: Goat anti-rabbit
antibody conjugated to phycoerythrin/Cy5, with an excitation peak of 488 nm and an
emission peak of 667 nm (Southern Biotech, Birmingham, AL).
Constructs: The following DNA constructs were used in this study: Human pCMV5myc-WNK1 was a generous gift by Dr. Chou-Long Huang. SPAK constructs GFP
SPAK T233/A (DU6190) and GFP SPAKWT (DU6188) were purchased at MRC-PPU
Reagents, University of Dundee, UK. Kv1.2 and KvB2 were developed in our lab
previously.
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Treatments: STOCK1S-50699 was purchased from MolPor (MolPort-002-144-727, Riga,
Latvia) and NaCl salt (58.44 g/mol, ≥99.0%) was purchased from Fisher Scientific
(BP358-10).
Cell Culture and Transfections
Human embryonic kidney 293T cells (HEKT-cells), Human embryonic kidney 293T
cells with WNK1 knocked out (WNK1KO cells) by CRISPR genomic editing (generated
as described in (Roy et al., 2015)), or human embryonic kidney cells stably expressing
Kvβ2 were used and cultured as previously reported (Nesti et al., 2004). Cells were
plated onto 60 mm petri dishes pre-coated in polyethylenimine and allowed to grow to
~60-80% confluence. Experimental plasmids were transfected into cells using a PEI
transfection method: Diluted DNA (5µg) was added to PEI (1µg/µL) at a 1:1 ratio and
immediately mixed by pipetting. Mixture was allowed to sit at room temperature for 15
minutes before being added drop wise to cells. Transfections were checked manually
with an arc-lamp microscope prior to proceeding (via 0.1µg EGFP DNA added to DNA
mixture). For immunoblotting, transfected cells were lysed 48 hours later. For flow
cytometry, 24 hours following transfection cells were re-plated to a density of 3.3 ×
104 cells/cm2 onto 35 mm petri dishes. Once cells adhered, media was aspirated, plates
were rinsed with sterile PBS (GIBCO life sciences), and media and new serum-free
media was given for overnight serum starvation (10-16 hours). In all experiments
comparing multiple cells lines, each were maintained at similar passage and treated
equally from plating to treatment. Results comparing the cell lines were analyzed blindly.
Surface Detection of Kv1.2 and Flow Cytometry
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Surface Kv1.2 detection: Cells were given a drug, vehicle, or no treatment before
application of 154mM solium azide as described previously (Nesti et al., 2004). Cells
were then lifted, put in a microcentrifuge tube, labeled for surface Kv1.2 by application
of 0.33µg/ml α-Kv1.2e, and antibody binding detected with fluorescently conjugated
anti-rabbit immunoglobulin G (IgG) (0.1µg/ml). Whole cell fluorescence was detected by
a single laser flow cytometer and distribution selection and background subtraction was
performed as previously described (Stirling et al., 2009).
Biochemical Sample Preparation
Immunoblot: For HEK293 cells, after lifting cells and removing a fraction for flow
cytometry plating, the remainder of transfected cells were allowed to settle and re-grow
to full confluence. 24-48 hours later, cells were rinsed (2 x ice-cold PBS), lifted in a lysis
buffer (described below for tissue homogenization), incubated for 10 minutes at 55°C in
Laemmli sample buffer containing 0.1 M dithiothreitol (DTT) (Sigma S3401-10VL), and
resolved by SDS-PAGE and protein immunoblot as previously described (Williams et al.,
2007).
Immunoprecipitation: Immunoprecipitation with soluble lysates from male, rat cerebellar
tissue (5-10 week old, Sprague Dawley, Chargles River, Quebec, Canada) was performed
with magnetic Dynabeads (Gibco, 30µl bead/ 1µg antibody) for 1 hr at 4°C. IPs were
washed three times with lysis buffer. Lysates and IPs were analyzed by SDS-PAGE and
Western blotting using anti-Kv1.2 (K14/16 mouse monoclonal, UC Davis), anti-WNK1
(rabbit polyclonal C-terminal WNK1 (GTX30695; GeneTex), anti-SPAK (rabbit
polyclonal SPAK (2281S; Cell Signaling), and anti-GAPDH (rabbit polyclonal GAPDH
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(ab9485; Abcam). Infrared secondary antibody signals were detected and quantified
using an Odyssey Infrared Imager (LI-COR). For co-IP analysis by immunoblot in Figure
1D, female rats (5 week old, Charles River, Quebec, Canada) were used. For IPs
processed for LC-MS/MS analysis, following SDS-PAGE electrophoresis gels were
stained with Coomassie Brilliant Blue G-250 (cat. #20279, Lifetechnologies) to produce
protein bands for excision.
Immunofluorescence
Multiphoton: Adult rat cerebellar slices (400 µM) were fixed (4% formaldehyde cardiac
perfusion followed by drop-in of room temperature 4% formaldehyde for 15 minutes),
permeabilized (10% ice-cold acetone, 5 minute), blocked (10% normal goat serum in
PBS, 1 hour), stained for Kv1.2 (1:200) and WNK1 (1:100) or SPAK (1:50) overnight,
rinsed (5 x 5 minute rocking in NGS, given secondary antibodies with conjugated
fluorescent probes (Alexa 488 and Alexa 586/647, 1 hour) and rinsed again (5 x 5
minute rocking in NGS). Images were obtained using a Zeiss LSM 7 multiphoton
microscope. The Zeiss LSM-7 Dedicated Multiphoton has four non-descanned PMT
detectors, two of which make up the highly sensitive Zeiss gallium arsenide phosphide
BiG detector. Multiphoton excitation is generated by a Coherent Chameleon Vision II
Titanium Sapphire pulsed IR laser, with dispersion compensation. The stage is a
motorized Prior Z-deck, which is fully integrated into the Zeiss Zen software. A 20X Plan
Apo 1.0 NA DIC VIS-IR water immersion lens is the main objective lens. The system
frame is a Zeiss Axio Examiner, specifically optimized for multiphoton microscopy.
Images were analyzed in Image J (NIH) and Zen Light 2012 software (Zeiss, Germany).
92

Co-localization was determine using the Image J Colocalization Point plugin with
automated threshold detection that was manually verified.
Widefield with Deconvolution: Adult rat cerebellar slices (50 µM) were fixed (4%
formaldehyde cardiac perfusion followed by drop-in of room temperature 4%
formaldehyde for 15 minutes), permeabilized (0.2% Triton X-100), blocked 10% normal
goat serum in PBS, and stained for Kv1.2 (1:200) and SPAK (1:50), and imaged using a
DeltaVision Restoration Microscopy System (Applied Precision). Images were acquired
with a 100X oil immersion lens using the SoftWorks software and analyzed with NIH
Image J. Colocalization was determine using the Colocalization Point plugin using
automated threshold detection that was manually verified.
Tissue Harvest and Membrane Fractionation
Cerebellar tissue was harvested from male (5-9 wk) Sprague Dawley rats and
homogenized in 10 mM HEPES (pH 7.4), 0.3M sucrose, 2mM EDTA, 1mM DTT, 1mM
NaF, 1mM NaOrthovanadate, 20mM BAPTA, 5mM NEM, 10 µM MG-132 and protease
inhibitors (HALT) using a 15mL dounce homogenizer (10-15 strokes). Nuclear proteins
were removed by low speed spin centrifugation (1000g for 10 min at 4°C) and samples
were separated into membrane fractions by ultracentrifugation (200,000 for 90 min at
4°C). The supernatant containing cytosolic proteins was discarded and remaining nonnuclear, membrane fraction was then re-suspended and lysed in 50mM Tris (pH 7.41),
150 mM NaCl, 1mM EDTA, 0.25% deoxycholate, 1% NP-40, 1mM DTT, 1mM NaF,
1mM NaOrthovanadate, 20mM BAPTA, 5mM NEM, 10 µM MG-132 and protease
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inhibitors (HALT cocktail of 100mM AEBSF*HCl, 80µM Aprotinin, 5mM Bestatin, E64, 1.5mM EDTA, 2mM Leupeptin, and 1mM Pepstatin A).
In Gel Digestion and Mass Spectrometry
Coomassie stained gel pieces were excised, diced, and subjected to in-gel digesting with
1.25ng/µl sequence grade modified trypsin. Peptides were extracted, re-suspended,
loaded, and separated by HPLC also as previously described (Connors et al., 2008).
MS/MS spectra obtained by the LTQ-XL linear ion trap mass spectrometer (Thermo
Electron) were also determined as previously described (Connors et al., 2008).
Instrument control was performed using the Xcalibur software package (version 2.0, SR2,
Thermo Electron). Raw data were searched against a rat sequence data base using
Sequest software (version 27, revision 12, Thermo Electron) with trypsin enzyme
specificity and a 2-Da mass tolerance. Cysteine residues had a static requirement of 71
Da for acrylamide adduction. Differential modifications of 79.96 Da for serine, threonine,
and tyrosine residues, as well as 114.0429 for lysines and 16 Da for methionine residues,
were permitted, and phospho-specific neutral loss increases to XCorr scoring were turned
off.
Statistical Analysis
Bar graphs within figures contain descriptive statistics representing the sample mean with
error bars representing standard error of the mean (SEM). Determination of statistical
difference between two independent measurements was detected by one-way Student’s t
test. Comparison of percent changes between pairs of independent measurements was by
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a two-way analysis of variance. Sample populations were considered to be significant at p
< 0.05: NS = p > 0.05, * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
Eyeblink Conditioning
Subjects
Male Wistar rats were obtained from Charles River (Quebec, Canada) and housed
in pairs upon arrival with access to food and water ad libitum. Rats were single housed
after surgery. The colony room was maintained on a 12 hour light-dark cycle (lights on at
7:00 AM and off at 7:00 PM). Rats weighed 200-300g prior to surgery. All behavioral
testing took place during the light phase of the cycle and all procedures were approved by
the Institutional Animal Care and Use Committee (IACUC) at the University of Vermont.
Surgery
Surgeries took place 4-6 days after arrival. Surgeries were performed under
aseptic conditions. Rats were anesthetized with 3% isoflurane in oxygen. Once the wound
had been cleaned and the skull was dried, four skull screw holes were drilled and skull
screws were placed as anchors for the head stage. The eyeblink portion of the surgeries
consisted of implantation of a bipolar stimulation electrode (Plastics One, Roanoke, VA)
that was positioned subdermally immediately dorsocaudal to the left eye. Two
electromyogram (EMG) wires for recording activity of the orbicularis oculi muscle were
constructed from two strands of 75-µm Teflon coated stainless steel wire soldered at one
end to gold pins fitted into a plastic threaded pedestal connector (Plastics One). The other
end of each wire was passed subdermally to penetrate the skin of the upper eyelid of the
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left eye and a small amount of insulation was removed so that the bare electrodes made
contact with the orbicularis oculi muscle. A ground wire was wrapped around two skull
screws at one end and the other end was also soldered to a gold pin fitted into the pedestal
connector. Once the ground wire and electrodes were placed, all were cemented to the
skull with dental cement. The wound was numbed with a local injection of 0.15 ml
bupivacaine, spread out over three points around the wound. The wound was salved with
antibiotic ointment (Povidone). At the end of the surgery, rats received subcutaneous
injections of Lactated Ringers (1ml) for hydration and ~0.3ml buprenorphine for postoperative analgesia. A second injection of the same concentration was given ~24-hours
after surgery. Rats were post-operatively checked daily for 4-5 days after surgery. Rats
were given 5-6 days to recover prior to eyeblink conditioning.
Apparatus
Eyeblink conditioning took place in one of four identical testing chambers (30.5 x
24.1 x 29.2 cm; Med-Associates, St. Albans, VT), each with a grid floor. The top of the
chamber was altered so that a 25-channel tether/commutator could be mounted to it. Each
testing chamber was kept within a separate electrically-shielded, sound attenuating
chamber (45.7 x 91.4 x 50.8 cm; BRS-LVE, Laurel, MD). A fan in each soundattenuating chamber provided background noise of approximately 60 dB sound pressure
level. A speaker was mounted in each corner of the rear wall and a light (off during
testing) was mounted in the center of the rear wall of each chamber. The soundattenuating chambers were housed within a walk-in sound-proof chamber.

96

Stimulus delivery was controlled by a computer running Spike2 software (CED,
Cambridge, UK). A 2.8 kHz, 80 dB tone, delivered through the left speaker of the soundattenuating chamber, served as the conditioned stimulus (CS). The CS was 295-ms in
duration. A 15-ms, 4.0 mA uniphasic periorbital stimulation, delivered from a constant
current stimulator (model A365D; World Precision Instruments, Sarasota, FL), served as
the unconditioned stimulus (US) during conditioning. Recording of the eyelid EMG
activity was controlled by a computer interfaced with a Power 1401 high-speed data
acquisition unit and running Spike2 software (CED, Cambridge, UK). Eyelid EMG
signals were amplified (10k) and bandpass filtered (100-1000 Hz) prior to being passed
to the Power 1401 and from there to the computer running Spike2. Sampling rate was 2
kHz for EMG activity. The Spike2 software was used to full-wave rectify, smooth (10ms
time constant), and time shift (10ms, to compensate for smoothing) the amplified EMG
signal to facilitate behavioral data analysis.
Eyeblink Conditioning Procedure
At the beginning of each session, each rat was plugged in, via the connectors
cemented to its head, to the 25-channel tether/commutator, which carried leads to and
from peripheral equipment and allowed the rat to move freely within the testing box.
Group Conditioned (n = 11) received 100 CS-US trials per day (intertrial interval = 20-40
sec) for 3 days. Group Untrained (n = 9) spent the equivalent amount of time in the
conditioning chamber, but without any stimuli and eyelid EMG activity was sampled
during 100 “no stimulus” trials per day for 3 days
Behavior Analysis
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For Group Conditioned, CS-US trials were subdivided into four time periods: (1)
a “baseline” period, 280-ms prior to CS onset; (2) a non-associative “startle” period, 080ms after CS onset; (3) a “CR” period, 81-280ms after CS onset; and (4) a “UR period,”
65-165ms after US onset. For Group Untrained, “no stimulus” trials were subdivided
using the same time periods. In order for a response to be scored as a CR, eyeblinks had
to exceed the mean baseline activity for that trial by 0.5 arbitrary units during the CR
period. Eyeblinks that met this threshold during the startle period were scored as startle
responses and were analyzed separately. The primary behavioral dependent measure for
all experiments was the percentage of trials with an eyeblink response during the “CR
period” across all 100 CS-US Paired trials (Conditioned group) and comparable “trial
periods” for the Untrained group for each session.
For the percentage of CRs, the data were analyzed using repeated measures
ANOVAs comparing between groups across sessions. As a confirmation, a one-way
ANOVA was run comparing the groups in the final day of acquisition. The criterion for a
significant effect was an α-level of 0.05 or below.
Results
WNK1 and SPAK interact with Kv1.2 in the Brain
Kv1.2 is expressed within the mammalian central nervous system, where, like
other ion channels, it interacts with protein complexes that influence its function. Kv1.2
function can be modulated by endocytic trafficking triggered by protein-protein
interaction in cultured cells (Hattan et al., 2002; Williams et al., 2007), however the
mechanisms governing Kv1.2 trafficking in the brain remain largely unknown. Recently,
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we have demonstrated that Kv1.2 trafficking is modulated, at least in part, by adenylate
cyclase/protein kinase A (AC/PKA) mediated trafficking. Regulation of Kv1.2 has
important consequences for cerebellar function, affecting not only PC dendritic
excitability but cerebellum-dependent associative learning as well (Williams et al., 2012).
To expand our understanding of Kv1.2 regulation beyond known or suspected
mechanisms, we used liquid chromatography tandem mass spectrometry (LC-MS/MS)
analysis of Kv1.2 isolated from cerebellar tissue extracts to systematically screen and
identify candidate proteins that may interact and modulate with Kv1.2 in the brain. Kv1.2
was immunoprecipitated from rat cerebellum and resolved using gel electrophoresis
(Figure1A). Protein components of the immunoprecipitate were identified using a high
mass accuracy LTQ-Orbitrap hybrid mass spectrometer (Thermo Electron) (Figure 1B).
The criteria for identification were 3 or more unique peptides with a Sequest crosscorrelation score (X-corr) of 2.4 or greater after first filtering all peptides to a less than
1% false discover rate using a concatenated reverse database during Sequest searches. A
parallel immunoprecipitation was done using mouse IgG and those non-specific
interactions were removed from the analysis. Among the most frequently observed
peptides are those from Kv1.2 itself, as well as proteins that we expect to interact with
Kv1.2, such as Kv1.1 (a closely related alpha subunit that multimerizes with Kv1.2) and
Kvβ2 (a Kv1.2 associated beta subunit), thus confirming the general methodology. We
also identified unexpected proteins. Four of these are not readily explained (Skiv2l2,
ZCCHC8, Acly and Pfkp). However, three others have functions suggesting they may be
potential novel modulators of Kv1.2, including the protein kinases WNK1 and SPAK or
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STK39 (Trim32 was investigated in a separate study). Using an LTQ Linear Quadrupole
Ion Trap Mass Spectrometer Plus Liquid Chromatography (LCMS), which can more
accurately detect lower-abundant protein peptides, we detected approximately 30
additional Kv1.2-specfic interacting proteins (data not shown), with WNK1 and SPAK
detected in five of five experiments with this instrument. Figure 1C provides peptides
identified in one experiment, highlighting those which suggest potential WNK1/SPAK
interaction. Immunoblot analysis corroborated the presence of WNK1 and SPAK in
Kv1.2 immunoprecipitated from the cerebella of both male and female adult rats (Figure
1D).
WNK1 Localizes with Kv1.2 in Purkinje Cells
WNK1 and SPAK are known to physically interact with each other and to
regulate ion transporter function in the brain (McCormick & Ellison, 2011; B. E. Xu,
Lee, et al., 2005), however their potential regulation of ion channels in the brain has been
unexplored. As a first step in determining whether WNK1 and SPAK are involved in
cerebellar Kv1.2 function we sought to characterize their relative anatomical localization.
Kv1.2 protein is expressed in two anatomical regions of the cerebellar cortex: the axon
terminals of basket cells (BC) where they influence inhibitory synaptic input to PCs, and
in the dendrites of PCs where they influence excitatory synaptic input (Khavandgar et al.,
2005; Koch et al., 1997). Previous in situ hybridization studies have identified WNK2
mRNA in cerebellar granule cells and PCs as well as neocortical pyramidal cells and
thalamic relay cells (Rinehart et al., 2011). A WNK1 reporting transgenic mouse found
WNK1 expression in cerebellar granule and PCs (Delaloy et al., 2006). Using
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immunofluorescence (IF) in cerebellar slices we confirmed WNK1 is highly expressed in
the cerebellum, with strong signal in PCs as well as some detection in granule cells and
molecular layer interneurons (Figure 2A). WNK1 signal was prominent in PCs soma
(Figure 2A, circle) as well as in PC dendrites within the molecular layer (Figure 2A,
arrows). Little WNK1 signal was detected in BC axon terminal (Figure 2A, box), a site
with dense Kv1.2 expression, suggesting that the WNK1 detected by LC-MS/MS was
associated with Kv1.2 originating in PCs but not BCs. Multiple attempts were made to
image SPAK as well, however the commercially available antibodies used gave poor
signal above background. Thus, the relative localization of SPAK and Kv1.2 in the
cerebellum was not determined (images depicting potential SPAK localization are
provided in Appendix B, Figure B:2).
WNK1 Influences Expression of Kv1.2 in Cells Stably Expressing Kvβ2
To determine if WNK signaling influences expression of Kv1.2, we first
performed a series of transient transfection experiments in cultured cells stably
expressing Kvβ2, an auxiliary Kv channel subunit important for Kv1.2 biosynthetic
trafficking (Manganas & Trimmer, 2000; Rhodes et al., 1996). First, we asked whether
WNK1 alters the surface expression of Kv1.2 measured using flow cytometry as
previously described (Nesti et al., 2004; Stirling et al., 2009). Images depict normalized
count which we interpret as an objective measure of surface Kv1.2. Kv1.2 surface
expression was significantly lower in cells expressing WNK1 relative to those expressing
Kv1.2 alone (-41%, t(df) = 12.45(46), p < 0.0001, n = 24 each) (Figure 3, top).WNK
kinases have been shown to decrease surface expression of ion channels through
101

trafficking, such as the WNK1-induced clathrin-mediated endocytosis of renal outer
medullary potassium channel (ROMK) channels (He et al., 2007; C. L. Huang et al.,
2008); however, WNK kinases can also decrease the total expression of ion channels,
such as the WNK4 driven increase of lysosomal degradation of renal large-conductance
Ca(2+)-activated K(+) (BK) channels (Z. Wang et al., 2013; Yue et al., 2013). We
therefore next asked if co-expression of WNK1 alters total Kv1.2 protein levels in these
cells. Interestingly, while co-expression of WNK1 significantly decreased channel
surface expression, total expression of Kv1.2 significantly increased (+110%, t(df) =
12.79(4), p < 0.0005, n = 5 (+ vector), 6 (+ WNK1) (Figure 3, middle and bottom).
Knockout of WNK1 Alters WNK1-induced Modulation of Kv1.2 Expression
HEK293 cells contain endogenous WNKs, including WNK1, which could
confound interpretation of experiments involving WNK1 over-expression. To address
this we used HEK293 cells in which endogenous WNK1 expression had been disrupted
(WNK1KO cells) using Clustered Regularly Interspaced Short palindromic Repeats
(CRISPRs)/Cas-mediated genome editing (developed and characterized in (Roy et al.,
2015)). These cells harbor the large-T antigen and are derived from a parent line of
HEK293T cells (Roy et al., 2015). Over-expression of WNK1 in the parent HEKT-cell
line produced a small but still significant decrease in surface Kv1.2 relative to cells
transfected with empty vector lacking the WNK1 gene (Figure 4, top left) (-9.2%, t(df)
= 4.61(22), p < 0.0001, n = 12 each). We next tested the effect of WNK1 on Kv1.2 in
WNK1KO cells. Interestingly, baseline surface Kv1.2 was significantly lower in the
WNK1KO relative to their parent HEKT cell line (-21.8%, t(df) = 12.60(22), p < 0.0001,
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n = 12 each). From that reduced Kv1.2 baseline, expression of WNK1 in the WNK1KO
cells caused surface Kv1.2 to increase significantly (+13.1%, t(df) = 2.84(21), p < 0.01 n
= 12 each). Immunoblotting detected increased total channel protein following coexpression of WNK1, however the increase was only significant in the HEKT-cells
(+33%, t(df) = 4.08(8), p < 0.005, n = 5 each) but not the WNK1KO cells (+28%, t(df) =
1.75(8), p = 0.119, n = 5 each). Together, these results show that co-expression of WNK1
alters Kv1.2 at the cell surface, and that the presence of endogenous WNK1 affects both
the baseline amount of Kv1.2 at the cell surface and the manner with which
overexpressed WNK1 influences the channel at the surface. WNK1 was not detected to
decrease total channel protein under the conditions tested. These results suggest that
WNK1 effects on Kv1.2 might be non-linear, with lower WNK1 levels (as in WNK1
expressed in WNK1KO cells) increasing Kv1.2 surface expression and higher levels
decreasing it.
Activation of Downstream SPAK/OSR1 Influences WNK1-induced Modulation of
Kv1.2
We next asked if the downstream kinases SPAK/OSR1 are involved in WNK1
induced alteration of surface Kv1.2. In order for SPAK/OSR1 to become phosphorylated
and subsequently activated by WNK kinases, SPAK/OSR1 must first interact with WNK
via a conserved carboxy-terminal (CCT) domain which binds to an RF(X)V/I domain
within WNK kinase (Villa et al., 2007). A small-molecule pharmacological compound,
STOCK1S-50699, disrupts this interaction, preventing WNK from activating
SPAK/OSR1, thus inhibiting WNK-dependent activity of SPAK/OSR1 on downstream
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targets (de Los Heros et al., 2014; Mori et al., 2013). We therefore used STOCK1S50699 to investigate whether WNK1 alters surface expression of Kv1.2 independently of
OSR1/SPAK (Figure 5A). To our surprise, treatment with STOCK1S-50699 (30
minutes, 20µM) decreased surface Kv1.2 levels in either HEKT-cells (-70%, t(df) =
15.55(15), n = 12 (vehicle), 6 (STOCK1S-50699), p < 0.0001) or WNK1KO cells (-68%,
t(df) = 13.58(16), n = 12 (vehicle), 6 (STOCK1S-50699), p < 0.0001). From this reduced
baseline, co-transfection with WNK1 in HEKT-cells no longer decreases surface Kv1.2
(+13.2%, t(df) = 1.47(9), p = 0.1762, n = 6 each), suggesting that the mechanism by
which WNK1 decreases surface Kv1.2 may be dependent on activation of SPAK/OSR1
by WNK kinases. Additionally, co-transfection of Kv1.2 with WNK1 in WNK1KO cells
treated with STOCK1S-50699 resulted in a significant increase of surface Kv1.2 (+50%,
t(df) = 4.95(10), p < 0.001, n = 6 each). Thus, expression of WNK1 in a WNK1 knockout
background drives an increase in surface Kv1.2, an effect greatly enhanced by blocking
SPAK/OSR1 activation. This finding suggests that WNK1 might affect Kv1.2 trafficking
in SPAK-dependent and SPAK-independent ways.
SPAK Influences Surface Kv1.2 Regardless of WNK1
Given that WNK1 is capable of modulating Kv1.2 via a SPAK-independent
mechanism, we asked whether SPAK can affect Kv1.2 independently of WNK1. Both
HEKT-cells and WNK1KO cells were transfected with either Kv1.2 alone (+ empty
vector) or co-transfected with SPAKWT (Figure 5B). Like WNK1, co-expression of
SPAK in HEKT-cells caused a significant decrease in surface Kv1.2 (-26%, t(df) =
4.53(16), p < 0.0005, n = 6 (+ vector), 12 (+SPAKWT). As also observed in Figure 5A,
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switching from HEKT-cells to WNK1KO cells significantly decreased baseline surface
Kv1.2 levels (-39%, t(df) = (4.89(10), p < 0.001, n = 6 each). However, co-expression
with SPAK in WNK1KO cells caused a further significant decrease in surface Kv1.2 (18%, t(df) = 2.31(16), p < 0.05, n = 6 (+ vector), 12 (+SPAKWT). Interestingly, SPAK
over-expression had no significant effect on total Kv1.2 protein levels (+13%, t(df) =
1.42(10) p = 0.189, n = 6 each), but significantly increased total Kv1.2 in WNK1KO cells
(+113%, 11.41(10), p < 0.0001, n = 6 each) (Figure 5C). This increase in total Kv1.2 is
similar to that caused by over-expression of WNK1 in the Kvβ2 stable HEK cell line
(Figure 3), suggesting the effect involved WNK1 activation of endogenous SPAK. To
address the possibility that over-expression of SPAK in WNK1KO cells might involve
other endogenous WNKs, we substituted SPAKWT with SPAKT233A, a version of
SPAK that cannot be phosphorylated and thus activated by WNKs (Vitari, Deak,
Morrice, & Alessi, 2005). In HEKT-cells, overexpression of SPAKT233A caused a
dramatic decrease in surface Kv1.2 (-38%, p < 0.0001, n = 6 (+ vector), 12
(+SPAKT233A), again implying that SPAK can decrease surface Kv1.2 independently of
WNK activation. Interestingly however, in WNK1KO cells, SPAKT233A resulted in a
moderate, non-significant decrease of surface Kv1.2 (-10%, t(df) = 1.38(14), p = 0.189, n
= 6 (+ vector), 10 (+ SPAKT233A). Therefore, although SPAK is able to regulate surface
Kv1.2 without being activated by WNKs, its effects on Kv1.2 trafficking is still
influenced by WNK1.
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Cerebellum-dependent Learning Decreases WNK1 Interaction with Kv1.2
Neurological WNK1 is highly localized to the cerebellum (Delaloy et al., 2006;
Rinehart et al., 2011), but its effect on overall cerebellar function is not known. Since we
demonstrated that WNK1 associates with Kv1.2 in the cerebellum (Figure 1), we
wondered if we could utilize cerebellar-dependent learning, a process we have shown
previously to involve Kv1.2, to demonstrate a functional role for WNK1 in the
cerebellum. In a previous study, blocking Kv1.2 via infusion of a specific Kv1.2 blocker,
tityustoxin-Kα, into the lobulus simplex of the cerebellum enhanced delay eyeblink
conditioning (Williams et al., 2012). Delay eyeblink conditioning (EBC) is a classical
conditioning paradigm that engages a discrete brainstem-cerebellar neural circuitry
(Thompson & Steinmetz, 2009). Furthermore, the neuropeptide secretin was previously
associated with Kv1.2 trafficking (Williams et al., 2012). Intracerebellar infusions of
secretin or a secretin receptor antagonist, facilitated and impaired acquisition of EBC,
respectively (Fuchs et al., 2014, Williams et al., 2012). Since suppression of Kv1.2
enhances EBC learning, we hypothesized that EBC itself might affect Kv1.2 regulation,
potentially by influencing the composition of its protein interactome. To test this, male
Wistar rats underwent either no training (Untrained) or a short delay EBC paradigm
(Conditioned) and LC-MS/MS analysis was used to identify Kv1.2 interacting proteins.
Immediately following the last trial of EBC training, rats were sacrificed and the lobulus
simplex region (HVI) of the cerebellum, ipsilateral to the trained eye, was harvested and
flash frozen in liquid nitrogen (Figure 6A). Rats in group Conditioned learned to make a
conditioned response significantly more than rats that those of group Untrained (Figure
6B). The tissue was pooled within experimental condition and subject to Kv1.2
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immunoprecipitation followed by analysis by LC-MS/MS (Figure 6C). Peptides of
Kv1.2 detected for each group were roughly equal (Conditioned: 55 peptide, Protein
XCorr = 3.76); Untrained 43 peptide, Protein XCorr = 3.66)). In both groups, WNK1 and
SPAK were detected as interacting proteins, however nearly half as many WNK1
peptides were detected in the Conditioned group (Conditioned: 10 total, 7 unique, Protein
XCorr = 3.03 vs. Untrained: 19 total, Protein XCorr = 3.02), with roughly equal SPAK
peptides between groups (Paired: 13 total, protein XCorr = 3.25; Unpaired: 9 total,
Protein XCorr = 3.10). The level of Kvβ2, which binds Kv1.2 readily, was unchanged
between groups (Conditioned: 39 total, Protein XCorr = 3.16; Untrained: 31 total, Protein
XCorr = 3.26). Immunoblot analysis and of Kv1.2 and co-immunoprecipitated WNK1
confirmed a learning-induced drop in WNK1 association with Kv1.2 caused by learning,
with the Untrained group showing a 3.6 fold increase in Kv1.2 associated WNK1 (Figure
6D).
Discussion
The WNK/SPAK signaling pathway has long been known to regulate cationchloride cotransporters in the kidney and more recently have been shown to do so in the
brain. Cation-chloride co-transporters have a major impact on intracellular chloride
concentration, and thus on the driving force for chloride currents through GABAA and
glycine receptors. The recent finding that WNK1 is a chloride sensor has led to the
hypothesis that WNK/SPAK phosphorylation and regulation of cation-chloride cotransporters has a key role in maintaining intracellular chloride levels during
neurotransmission involving ligand-gated chloride channels. The findings presented here
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expand this paradigm by identifying the voltage-gated potassium channel Kv1.2 as a new
target for WNK and SPAK in the brain.
Using mass spectrometry, we identified WNK1 and SPAK as components of the
cerebellar Kv1.2 interactome (Figure 1). We then used HEK239 cells as a model system
to assess the role of WNK1 and SPAK on Kv1.2 function (Figures 3-5). Since Kv1.2
electrophysiological function is regulated by endocytic trafficking (Nesti et al., 2004), we
assessed the effects of WNK1 and SPAK on Kv1.2 levels at the cell surface. Overexpression of either WNK1 or SPAK decreased Kv1.2 surface levels in wild-type
HEK293 cells (Figures 3-5). However, in HEK cells in which endogenous WNK1
expression had been ablated using CRISPR genomic editing (Roy et al., 2015), overexpression of WNK1 increased surface Kv1.2 levels (Figures 4-5). We attribute the
WNK1 induced drop in Kv1.2 surface levels in wild-type HEK192 cells to its activation
of SPAK since the dramatic internalization of Kv1.2 by SPAK over-expression was not
eliminated in WNK1 knockout cells (Figure 5). In contrast, disruption of WNK-SPAK
interaction by over-expressing a version of SPAK lacking the WNK phosphorylation site
(SPAK-T233A) or with the small-molecule inhibitor Stock1S-50699, reversed the
polarity of the effect of WNK1 on Kv1.2 surface levels (Figure 5). Collectively, these
findings suggest that WNK1 can affect Kv1.2 trafficking not only by activating SPAK,
but also by a SPAK-independent mechanism as well.
Given that WNK1 is a chloride sensor, it is possible that WNK/SPAK signaling
might link Kv1.2 function to GABAA or glycine receptor activity in the brain. Purkinje
cell dendrites, which harbor both Kv1.2 and WNK1 (Figure 2), receive abundant input
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from GABAergic interneurons. The primary effect of this synaptic input is inhibitory via
GABAA receptor mediated chloride influx. The resulting increase in intracellular chloride
levels would be expected to inhibit WNK1 and, as hypothesized for other cell types,
relieve WNK1 mediated inhibition of KCC1. This, in consequence, would increase
chloride extrusion by KCC1, thus providing a feedback mechanism for maintaining
intracellular chloride homeostasis. However, our data suggests a parallel mechanism
whereby chloride mediated inhibition of WNK/SPAK activity would also decrease
endocytosis of Kv1.2. This would in turn increase Kv1.2 levels at the cell surface,
facilitating its ability decrease dendritic excitability. This hypothetical mechanism would
suggest a novel role for WNK1 as a mechanism for linking inhibitory transmission with
Kv1.2 via a mechanism that does not directly involve voltage sensitivity. Such a
mechanism could serve to extend the inhibitory effect of GABAergic transmission on
membrane excitability beyond the period of direct GABAA receptor activation.
Intriguing evidence that WNK1 is involved in Kv1.2 regulation in vivo comes
from our finding that the physical interaction between WNK1 and Kv1.2, or at least the
stability of the interaction during immunoprecipitation, is significantly altered by
experience in live, behaving animals. Pairing of CS and US in an EBC paradigm roughly
halved the amount of WNK1 that co-immunoprecipitated with Kv1.2 (Figure 6).
Interestingly, the channel’s interaction with SPAK was not decreased. Why this is the
case remains to be determined, although it might indicate that WNK1 and SPAK interact
with Kv1.2 via different mechanisms, potentially via different sites within the
channel. We also note that phosphorylation at two sites within Kv1.2, S434 and S468 was
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detected in the CS-US paired but not unpaired condition. Whether this is related to EBC
induced changes in WNK1 interaction with Kv1.2 remains to be determined. The
functional effect of decreased WNK1 interaction with Kv1.2 can also only be speculated
on at this point. In previous studies we have shown that suppressing Kv1.2 activity
enhances EBC (Fuchs et al., 2014; Williams et al., 2012). It is possible that, as in HEK
cells (Figures 3-5), cerebellar WNK1 might act independently of SPAK to enhance
surface Kv1.2 levels. Reducing WNK1 interaction with Kv1.2 would thus reduce surface
Kv1.2 levels, possibly enhancing EBC.
Throughout our experiments, we did not deduce whether WNK1 or SPAK
directly bind Kv1.2, leaving the possibility that other intermediary proteins may
contribute to WNK signaling induced trafficking of Kv1.2. Additionally, the current
studies do not directly address the mechanism by which WNK1 or SPAK affect surface
Kv1.2 levels. Our findings that the WNK-induced decreases in surface Kv1.2 levels in
HEK293 cells was accompanied by an apparent increase in total Kv1.2 protein suggest
that WNK modulates endocytic trafficking, either by enhancing endocytosis or
decreasing recycling of endocytosed channel back to the plasma membrane. It is likely
that WNK1 or SPAK affect Kv1.2 phosphorylation and future in vitro kinase assays or
quantitative LC-MS/MS approaches such as Stable Isotope Labeling in Culture (SILAC)
could help determine this. Finally, intracranial infusion of Stock-1S-50699 into the
lobulus simplex of adult rats prior to EBC training would provide a powerful future
experiment to observe whether disruption of WNK:SPAK binding alters the progression
of EBC.
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Figure Legends
Figure 1. Kv1.2 associates with WNK1 and SPAK kinases in the cerebellum. A:
Representative protein gel scan following immunoprecipitation of Kv1.2 or mouse IgG
from cerebellar tissue. Arrows indicate molecular weight range for Kv1 channels (~80100kDa), WNK kinases (> 250kda), and SPAK (~65Kda). B: A full interactome of
Kv1.2 in the cerebellum as detected by LTQ Linear Quadrupole Ion Trap-Orbitrap Mass
Spectrometer Plus Liquid Chromatography (Thermo-Fisher Scientific) following Kv1.2
IP (non-specific proteins detected in IgG IP removed). Peptides detected relative to
WNK:SPAK interaction are highlighted for observation. C: Tryptic peptides from
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WNK1 and SPAK detected by LTQ Linear Quadrupole Ion Trap Mass Spectrometer Plus
Liquid Chromatography (Thermo-Fisher Scientific) following IP of Kv1.2 in the
cerebellum. No peptides of WNK1 or SPAK were detected from IgG controls. WNK
peptides containing SPAK binding RF(x)V/I domain and SPAK T-loop phosphorylation
are highlighted. Non-Orbitrap interactome of Kv1.2 was performed in 3 total repeats.
D: Immunoblots demonstrating co-IP of both WNK1 (left, 7.5% gel) and SPAK (right,
10% gel) with Kv1.2 from female, cerebellar tissue.
Figure 2. WNK1 localizes to PC cell bodies and dendrites. A: Multiphoton imaging
demonstrating that WNK1 (red) strongly localizes to PC cell bodies and processes of the
molecular layer where Kv1.2 is also present (green). Insert and merge show that the
overlap within the dendritic processes is not exact, with WNK1 giving a punctate
appearance alongside the processes. Insert scale bar represents 10µm. B: Secondary only
controls showing no non-specific fluorescence within the microscopy. Multiphoton
images were obtained on a Zeiss LSM 7 multiphoton microscope with a 20X water
immersion lense and analyzed in Image J (NIH) and Zen Light 2012 software. Widefield
images were acquired using a 100X oil immersion lenses using the SoftWorks software
and analyzed with NIH Image J. Colocalization was determine using the Colocalization
Point plugin using automated threshold detection that was manually verified. Neither
SPAK nor Kv1.2 was localized to PC pineaus using Alexa 647 by either multiphoton or
widefield microscopy.
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Figure 3. WNK1 alters both total and surface Kv1.2 expression in HEK293 cells
stably expressing Kvβ2. Top: WNK1 co-expressed with Kv1.2 caused a significant
decrease in surface Kv1.2 expression in HEK293 cell lines stably expressing beta subunit
Kvβ2 (-41%, t(df) = 12.45(46), p < 0.0001, n = 24 each). Middle, bottom: WNK1 coexpressed with Kv1.2 caused a significant increase in total Kv1.2 expression in HEK293
cell lines stably expressing Kvβ2 (+110%, t(df) = 12.79(4), p < 0.0005, n = 5 (+ vector), 6
(+ WNK1).

Figure 4. Knockout of WNK1 alters the response of overexpressed WNK1 in
HEK293T cells. Top: In control HEK293T cells (HEKT-cells), WNK1 also but more
modestly significantly decreased surface Kv1.2 (-9.2%, t(df) = 4.61(22), p < 0.0001, n =
12 each). In HEK293T cells deficient of endogenous WNK1 (WNK1KO cells),
overexpression of WNK1 caused surface Kv1.2 to significantly increase +13.1%, t(df) =
2.84(21), p < 0.01 n = 12 each. Switching from HEKT-cells to WNK1KO cells also
casued baseline surface Kv1.2 to drop (-21.8%, t(df) = 12.60(22), p < 0.0001, n = 12
each). Middle, bottom: Co-expression of WNK1 caused a significant increase in HEKTcells (+33%, t(df) = 4.08(8), p < 0.005, n = 5 each) and a similar although non-significant
increase in WNK1KO cells compared to Kv1.2 + vector only ((+28%, t(df) = 1.75(8), p =
0.119, n = 5 each).

Figure 5. SPAK influences Kv1.2 expression in HEK293 cells.
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A: After treating either HEKT-cells or WNK1KO cells with the WNK/SPAK binding
inhibitor stock-1S50699, Kv1.2 baseline surface expression (Kv1.2 + empty vector)
dramatically dropped compared to vehicle treated cells in both HEKT-cells (-70%, t(df) =
15.55(15), n = 12 (vehicle), 6 (STOCK1S-50699), p < 0.0001) or WNK1KO cells (-68%,
t(df) = 13.58(16), n = 12 (vehicle), 6 (STOCK1S-50699), p < 0.0001). From this baseline,
WNK1 overexpression in HEKT-cells caused a non-significant increase of surface Kv1.2
(+13.2%, t(df) = 1.47(9), p = 0.1762, n = 6 each) and a dramatic, significant increase in
WNK1KO cells (+50%, t(df) = 4.95(10), p < 0.001, n = 6 each). B: Top: Co-expression
of Kv1.2 with SPAKWT caused a significant decrease in surface Kv1.2 in both HEKTcells (-26%, t(df) = 4.53(16), p < 0.0005, n = 6 (+ vector), 12 (+SPAKWT) and
WNK1KO cells (-18%, t(df) = 2.31(16), p < 0.05, n = 6 (+ vector), 12 (+SPAKWT), and
switching from HEKT-cells to WNK1KO cells significantly dropped baseline surface
Kv1.2 (-39%, t(df) = (4.89(10), p < 0.001, n = 6 each). In T-cells, replacing SPAKWT
with WNK1 insensitive SPAKT233A still caused a significant decrease of surface
channel (-38%, p < 0.0001, n = 6 (+ vector), 12 (+SPAKT233A) and in WNK1KO cells,
replacing SPAKWT with SPAKT233A caused a non-significant decrease in surface
Kv1.2 (-10%, t(df) = 1.38(14), p = 0.189, n = 6 (+ vector), 10 (+ SPAKT233A). Middle,
bottom: Co-expression with SPAK did not significantly increase total channel protein in
HEKT-cells (+13%, t(df) = 1.42(10) p = 0.189, n = 6 each) but did in WNK1KO cells
(+113%, 11.41(10), p < 0.0001, n = 6 each).
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Figure 6. WNK1 association with Kv1.2 is decreased in the lobules simplex following
EBC learning. A: Wistar were given either a paired conditioning or non-stimulated 3
session training session to develop EBC prior to LC-MS/MS analysis. Approximate
region of the cerebellum containing the lobules simplex was dissected and pooled
together for each training group while the remainder was discarded (2 paired subjects
were removed for equal sample sizes). Protein gel scan of Kv1.2 IPs from trained or
untrained lobules simplex dissections demonstrates density of proteins similar to whole
cerebellar homogenates (Figure 1). C: Demonstration of successful acquisition training
for the conditioned group. B: LC-MS/MS output shows decreased WNK1 peptide
detection following acquisition compared to untrained. SPAK (STK39) peptides were
lightly increased within a reasonable range of error. Two phosphorylation states of
Kv1.2 (S434 an S468) were detected only in the Conditioned group while S440/441 was
detected equally. D: Immunoblot of the same IPs detected a 3.6 fold decrease of WNK1
protein that co-IP compared to the Conditioned group.
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Figures

Figure 3:1 Kv1.2 associates with WNK1 and SPAK kinases in the cerebellum.
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Figure 3:2 WNK1 localizes to PC cell bodies and dendrites.
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Figure 3:3 WNK1 alters both total and surface Kv1.2 expression in HEK293 cells
stably expressing Kvβ2.
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Figure 3:4 Knockout of WNK1 alters the response of overexpressed WNK1 in
HEK293T cells.
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Figure 3:5 SPAK influences Kv1.2 expression in HEK293 cells.
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Figure 3:6 WNK1 association with Kv1.2 is decreased in the lobules simplex
following EBC learning.
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CHAPTER 4: COMPREHENSIVE DISCUSSION
Overview
In the preceding chapters, a proteomic assessment of Kv1.2 purified from native
tissue extracts enabled the discovery of novel protein associations with Kv1.2 in the
cerebellum. A sample of these associations was selected for two studies in which the
interactions were further validated and tested in cultured cells which ultimately yielded
working models for Kv1.2 modulation in the brain. These models also further utilized the
power of mass spectrometry by incorporating post-translational modifications of both
Kv1.2 and interacting protein partners that were also identified by mass spectrometry
from cerebellar tissue.
In Chapter 2, the hypothesis that the ubiquitin ligase Trim32 modulates surface
Kv1.2 through channel ubiquitylation was tested. Using mutagenesis, quantitative
proteomics, and biochemistry, a model was developed in which Trim32, through the
coordinated interplay of channel phosphorylation and ubiquitylation, modulates
expression of Kv1.2 at the plasma membrane.
In Chapter 3, the hypothesis that the chloride-sensitive WNK signaling pathway
regulates Kv1.2 was tested. Using a knockout cell line, pharmacology, and mutagenesis,
it was determined that both WNK1 and its downstream target SPAK impact Kv1.2
expression at the plasma membrane, and a working model was developed in which
WNK1 and SPAK modulate Kv1.2 through complementary mechanisms. In the
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conclusion of this study, mass spectrometry and biochemistry demonstrated that the
association of WNK1 with Kv1.2 changed following cerebellum-dependent learning.
Given that suppression of Kv1.2 can alter cerebellar-dependent learning (Williams et al.
2012), this provided framework for future studies to investigate a potential impact of this
association on behavior.
Collectively, this work demonstrates the first evidence to support roles for Trim32
and WNK1 on the expression and trafficking of voltage-gated potassium channels.
However, both studies raise several questions.
Excitability Control as a Role for Trim32 in the Adult Brain
Contribution of Trim32 to Neuronal Excitability
The preceding work in Chapter 2 demonstrated evidence for an interaction
between Kv1.2 and Trim32 and proposed a complex model of modulation of Kv1.2 by
Trim32 in the brain. We did not, however, investigate the influence of Trim32 on
membrane potential. There are currently no reported pharmacological agents that
manipulate Trim32 activity or expression, complicating our ability to investigate Trim32
in vivo. Although Trimk32KO mice are not commercially available and we were unable
to obtain a donation from other labs possessing Trim32KO colonies, companies such as
Applied Biological Materials (ABM) and Santa Cruz have recently made viral constructs
that utilize CRISPR technology to genetically remove Trim32 in vivo. Comparing the
electrophysiology of neurons of a Trim32KO rodent to that of a normal one would
provide a relatively straight forward approach to address this question. Alternatively, and
perhaps more simplistically, culture systems such as HEK cells which lack endogenous
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Trim32 could be utilized to compare membrane potential from cells transiently
transfected with a Trim32 construct to those that were not.
Aside from the work presented in Chapter 2, the most compelling evidence in the
literature that links Trim32 to neuronal excitability is the recent connection of Trim32
and Autism co-morbid with epilepsy.
Epilepsy Co-morbid with Autism
According to the Center for Disease Control (CDC), one in 68 children in the
United States have a form of Autism Spectrum Disorder (ASD), a spectrum of complex
neurological diseases characteristic of difficulties in social interaction, verbal and
nonverbal communication, and repetitive disorder. Among ASD patients, a seizure
occurrence rate of up to 40% of ASD has been reported (Tuchman & Rapin, 2002).
Anywhere from 7-46% of ASD patients are also affected with epilepsy (Bolton et al.,
2011; Danielsson, Gillberg, Billstedt, Gillberg, & Olsson, 2005; Giovanardi Rossi, Posar,
& Parmeggiani, 2000), a seizure disorder which involves disturbances in electrical
activity in the brain caused by brain injury, genetics, or as is often the case, for unknown
reasons.
Epilepsy is one of the most common neurological diseases occurring in children,
with incidence ranging from 41-187/100,000 dependent of demographic factors
(reviewed recently in: (Camfield & Camfield, 2015)). Like ASD patients, who may
display symptoms of epilepsy, 15-35% of children with epilepsy may show symptoms of
ASD (Matsuo, Maeda, Sasaki, Ishii, & Hamasaki, 2010; Saemundsen, Ludvigsson,
Hilmarsdottir, & Rafnsson, 2007; Steffenburg, Steffenburg, & Gillberg, 2003). Despite
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the frequent co-morbidity of these neurological diseases, the mechanisms behind the cooccurrence of epilepsy and ASD phenotypes are unclear and complex. Various
neurobiological mechanism critical to early brain development seem to be altered, and
key neuronal processes such as synaptic plasticity, GABA transmission, and functional
connectivity are impacted (Stafstrom, Hagerman, & Pessah, 2012; Tuchman, Moshe, &
Rapin, 2009).
Epilepsy Co-morbid with Autism May Link Trim32 with Membrane Excitability
Mutations of the Trim32 gene have been identified as a risk factor for ASD, and a
recent study on genetic screening of ASD patients identified Trim32 as one of 12
candidate genes associated with comorbidity of ASD and epilepsy in children. The
majority of genes identified are involved with formation, maintenance, or remodeling of
the synapse, for the first time placing Trim32 in a category of genes that influence
neuronal and synaptic activity (Lionel et al., 2011; Lionel et al., 2014; Lo-Castro &
Curatolo, 2014).
Trim32 is a small gene nested within an intron of ASTN2 located along
chromosome locus 9q33.1. A recent study utilized clinical microarray data to
systematically screen for novel mutations at this loci and found that exonic deletion or
duplication of ASTN2 was significantly enhanced in male patients with
neurodevelopmental disorders (NDD), and 27 of 46 deletions (no duplications) also
affected Trim32. Twelve of the subjects referred for the genetic study were ASD patients.
The authors also utilized comprehensive gene expression data from the BrainSpan
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database and found that, in concordance with Trim32KO mice, Trim32 is most highly
expressed in the cerebellar cortex (Lionel et al., 2014).
As pointed out by De Smet et al., neuroanatomical, neuroimaging, and clinical
studies combined have extended the role of the cerebellum beyond motor control to the
modulation of cognitive and affective processing (De Smet, Paquier, Verhoeven, &
Marien, 2013). Damage to the cerebellum by injury, birth defect, and even tumor growth
can lead to neurological disruptions such as emotional outbursts, mood changes,
difficulty understanding social cues, and repetitive behaviors, all of which are
symptomatic of ASD. Additionally, reduced PC volume in the cerebellum is a consistent
finding of post-mortem ASD patients and rodent models (Kern, 2003; Piochon et al.,
2014; Whitney et al., 2008), and mice lacking the Autism-linked genes TSC1/2 displayed
both decreased PC expression and Autistic-like behavior (Reith et al., 2013; Tsai et al.,
2012).
Altogether, epilepsy within ASD may link a role for Trim32 in neuronal
excitability, and the cerebellum provides an appropriate route for investigating this role
given the high expression of Trim32 and emerging roles of ASD pathology. Additionally,
Kv1 channels, which are also highly expressed in the cerebellum, are strongly involved in
seizures, a marked phenotype of epilepsy involving altered neuronal excitability.
The Role of Kv1.2 in Epilepsy and Seizure
Mutation or deletion of the genes encoding Kv1.1 and Kv1.2 result in
neurological disorders with disrupted excitability in both humans and rodents (Adelman,
Bond, Pessia, & Maylie, 1995; Brew et al., 2007; Buffington & Rasband, 2011;
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Kullmann & Hanna, 2002; Leao, Berntson, Forsythe, & Walmsley, 2004; Smart et al.,
1998; Wimmer, Reid, So, Berkovic, & Petrou, 2010). Both Kv1.1 and Kv1.2 null mice
have spontaneous seizures, however the seizure disorder models are different (Robbins &
Tempel, 2012). Deletion of Kv1.1 can cause epilepsy in mice with spontaneous seizures
throughout life (Smart et al., 1998), and only half of the Kv1.2 null mice survive to
adulthood (Wenzel et al., 2007). Kv1.2 null mice present a more severe seizure and are
lethal beyond post-natal day 19 (Brew et al., 2007) with seizures characteristic of those in
the brainstem (Browning, 1986; Gale, 1992). Seizure activity produces a reduction of
Kv1.2, but not Kv1.1, mRNA in dentate granule cells of the hippocampus, and treatment
with anticonvulsive drugs both protect animals from seizure and prevent reduction of
Kv1.2 (Tsaur, Sheng, Lowenstein, Jan, & Jan, 1992). If epilepsy connects Trim32 to
neuronal excitability, then Kv1 channels such as Kv1.2 are clear candidates for
involvement in this mechanism.
Conclusion
The work of Chapter 2 provided evidence that the ubiquitin ligase Trim32
associates with Kv1.2 in the brain and modulates the channels’ function. Given the
literature linking Trim32 with epilepsy in ASD patients, and the pivotal role Kv1
channels can play in epileptic seizure, further experiments may identify Trim32 as a
modulator of neuronal excitability and thus provide a novel physiological role for Trim32
in the brain. Additionally, Appendix A presents data that demonstrates Trim32 also
localizes with Kv1.2 in hippocampal neurons, and given the mutual connection of these
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proteins with seizure, the hippocampus may also useful venue for future experimental
investigations of Trim32 and neuronal excitability.
GABAergic Inhibition as a Model Role for WNK1/SPAK Modulation of Kv1.2 in
the Brain
The preceding work in Chapter 3 identified components of the chloride-sensitive
WNK kinase pathway associating with Kv1.2 in the brain, and proposed a model of
WNK1 and its downstream target SPAK providing complementary modulation of the
channel at the cell surface. WNK1’s best described role in the literature is to activate
SPAK/OSR1 in response to alterations of intracellular chloride, although it can have
functionality that may be independent of its kinase domain and SPAK activation. The
following section will provide evidence for a testable model of GABAergic inhibition of
Purkinje cells through chloride-influenced WNK/SPAK signaling and Kv1.2 trafficking.
Chloride Inhibits WNK1 Kinase Activation of SPAK
Chloride inhibits WNK1 kinase activity, which primarily targets downstream
kinases SPAK/OSR1. The chloride ion stabilizes the inactive conformation of WNK1 by
binding the kinase domain, preventing auto-phosphorylation, and thereby preventing the
ability of SPAK to be activated by WNK1 phosphorylation. This mechanism is what
defines WNK1 as an intracellular chloride sensor (Piala et al., 2014). However, even with
an inactivated kinase domain, WNK1 may still have kinase-independent functionality.
WNK1 Traffics Membrane Proteins without Kinase Activity
WNK1 also induces clathrin-dependent endocytosis of ROMK (Zagorska et al.,
2007) which requires binding outside its kinase domain, and mutants lacking kinase
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activity can still inhibit the channel (H. R. Wang, Liu, & Huang, 2008). Additionally,
WNK1 activates the Serum and Glucocorticoid-induced Kinase (SGK) 1 (SGK1) to
impact the membrane expression of epithelial sodium channel (ENaC) by requiring only
the N-terminal residues and not the kinase domain (B. E. Xu, Stippec, Lazrak, et al.,
2005). Given the kinase independence, these functionalities of WNK1 are also likely
independent of chloride.
Chloride May Determine the Route WNK1/SPAK Influence Surface Kv1.2
As chloride inactivates WNK1 kinase activity, reduced intracellular chloride
activates WNK kinases (Piala et al., 2014). Particularly, reduced intracellular chloride has
been shown to activate SPAK/OSR1 and eventual major downstream targets of the
chloride-response pathway such as NKCC1 in secreting epithelia (Lytle & Forbush,
1996). In the case of NKCC2, the main transporter that extrudes chloride through this
pathway in the brain (de Los Heros et al., 2014), the transporter activation by reduced
intracellular chloride is blocked by WNK mutants that affect the WNK-SPAK docking
interaction (Ponce-Coria et al., 2008).
In relation to the topics of this thesis, decreased extracellular chloride reduces the
current of Kv1.5 and Kv2.1, providing the first evidence for Cl- induced modulation of
Kv channels. (X. Li, Surguchev, Bian, Navaratnam, & Santos-Sacchi, 2012). Hypotonic
low-chloride conditions rapidly activate WNK kinase isoforms, including
SPAK/OSR1(Lenertz et al., 2005). Thus, in conditions where WNK1 kinase activity is
expected to be increased, at least some Kv channel currents are also suppressed. This is in
line with our conclusions from Chapter 3, where SPAK or WNK1 activated SPAK
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activity decreases Kv1.2 at the plasma membrane. If increasing chloride inside the cell
increases Kv channel current, and if chloride inactivates WNK1 activation of SPAK,
perhaps increased intracellular chloride triggers WNK1 to favor its SPAK-independent
increase of Kv1.2 at the membrane surface. Along these lines, decreased intracellular
chloride would then activate WNK1 kinase activity and, through SPAK, decrease Kv1.2
from the surface. Experiments that directly manipulate intracellular chloride need to be
performed to validate this model, but it seems at least possible that chloride may be the
factor with which dictates how this signaling pathway influences Kv1.2. In the brain,
fluctuations of intracellular chloride occur often from the neurotransmitter GABA.
WNK1 has been hypothesized to be involved with GABAergic inhibition in the brain, but
this concept is for the most part speculative (Alessi et al., 2014).
Proposed Model of GABAergic Inhibition of Kv1.2 by WNK/SPAK Signaling
GABAA receptors (GABAAR) comprise the main inhibitory neurotransmission
system in the brain, eliciting hyperpolarization through chloride ion influx. In a previous
publication, treatment of live cerebellar slices with gabazine, a drug that blocks GABAA
receptors, resulted in a reduction of Kv1.2 measured at the cellular surface (Williams et
al., 2012). In Chapter 3 and Appendix B, immunofluorescence demonstrated WNK1 and
likely also SPAK are expressed in the GABAergic Purkinje cells of the cerebellar cortex
which receive GABAA inhibition from interneurons such as basket cells. Binding of
GABA to GABAA receptors promotes the passage of chloride through the channel and
into the cell, and therefore blockade of GABAA receptors with the drug gabazine is
hypothesized to decrease intracellular chloride and therefore increase WNK1 kinase
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activity and thus WNK1-activation of SPAK. This suggests the following model
illustrated in Figure 1: GABA release by cerebellar inhibitory interneurons bind PC
GABAARs and cause an increase of [(Cl-)i]. The elevation of [(Cl-)i] decreases WNK1
kinase activity which in turn results in increases of Kv1.2 expression at the neuronal
plasma membrane. Kv1.2 maintained at the surface provides hyperpolarization and thus
extends the overall GABAergic inhibition of the PC. Conversely, under conditions where
inhibitory neurons release less GABA, less chloride passes into the PC and the decrease
of [(Cl-)i] allows increased activation of WNK1 kinase activity and thus favors WNK1 to
activate SPAK and internalize Kv1.2 from the neuronal membrane. Decreased surface
Kv1.2 depolarizes the PC leading to enhanced excitability. Although speculative, this
hypothesis suggests a novel and currently unexplored voltage-independent link between
GABAA receptor function and voltage-gated ion channels.
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Figure 4:1 Proposed model of Kv1.2 modulation by GABA induced WNK1/SPAK
signaling. GABA release by cerebellar inhibitory interneurons bind PC GABAARs and
cause an increase of [(Cl-)i]. The elevation of [(Cl-)i] decreases WNK1 kinase which in
turn results in increases of Kv1.2 expression at the neuronal plasma membrane. Kv1.2
maintained at the surface provides hyperpolarization and thus extends the overall
GABAergic inhibition of the PC. Conversely, under conditions where inhibitory neurons
release less GABA, less chloride passes into the PC and the decrease of [(Cl-)i] allows
increased activation of WNK1 kinase activity and thus favors WNK1 to activate SPAK
and internalize Kv1.2 from the neuronal membrane. Decreased surface Kv1.2
depolarizes the PC leading to enhanced excitability.
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Are Trim32 and WNK1 Pathways Linked?
Determining whether Trim32 and WNK signaling modulate Kv1.2 through
separate or linked pathways is not straightforward. The preceding work demonstrated
complex, duel mechanisms for modulating Kv1.2 by both routes. Cellular growth
conditions and potential patterns of post-translational modification can sway Trim32’s
route, while endogenous WNK1 can influence whether WNK1 activates SPAK and alters
it’s route of modulation. Additionally, compensatory effects from other WNK kinases
and ubiquitin ligases must be accounted for. It is especially interesting to speculate that
WNK1 or SPAK affect phosphorylation proximal to Trim32 ubiquitylation sites, since, as
described in Chapter 2, phosphorylation at these sites influence the effect of Trim32 on
Kv1.2 trafficking. Figure 2 demonstrates a replicate series of experiments where coexpression of Trim32 and WNK1 together abolished the effects of either enzyme coexpressed individually. Although tempting to infer a connection, the complex
mechanisms by which either enzyme modulates the channel makes this result speculative
at best. Future experiments are needed to further examine whether Trim32 and WNK1
cooperate to modulate Kv1.2.
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Figure 4:2 Co-expression of both Trim32 and WNK1 abolishes individual effects on
surface Kv1.2 by each enzyme. As demonstrated in Chapters 2 and 3, co-expression of
Trim32 (wild-type) causes Kv1.2 to significantly increase in surface expression (Chapter
2), while, conversely, co-expression of WNK1 causes Kv1.2 to significantly decrease in
surface expression (Chapter 3). When equal amounts of Trim32 and WNK1 were both
co-expressed in the same cells with Kv1.2 (total amount of each was equal to the
individual co-expressions), no significant change was observed to Kv1.2 surface
expression. **** indicates p < 0.0001. Note: data presented in this graph was also
separately presented in graphs of Chapters 2 and 3.

Conclusions
Altogether, this work provides novel mechanisms by which voltage-gated
potassium channels may be regulated in the brain. Regulation of Kv1.2, the channel
focused on in this work, can influencing neuronal excitability and ultimately behavior in
the brain (Williams et al., 2012), and therefore this work provides framework for future
studies investigating excitability in regard to brain function of both the normal and
disease state. Regulation of Kv1.2 by the WNK/SPAK signaling pathway may provide
further understanding of GABAergic inhibition in cerebellar neurons that underlie
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numerous neuronal functionalities. Regulation of Kv1.2 by Trim32 may provide a link
for Trim32 and neuronal excitability that could translate into a model addressing the
epilepsy connection of Trim32 and ASD.
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APPENDIX A: DATA RELATING TO CHAPTER 2
Background
The following data presented was collected during the development of Chapter 2
but was not incorporated into the final seven figures of the publication in preparation.
These findings may provide further clarity and breadth to the concepts present in Chapter
2.
Results and Discussion
Mutation of Either C or N Terminal Kv1.2 Lysines Cripple Trim32-induced Increase of
Surface Channel
HEK293 cells co-expressing Kv1.2 and Trim32WT plated to low confluence
display increased surface Kv1.2 detection by flow cytometry compared to Kv1.2 transient
transfection alone (+ empty vector). In Chapter 2, it was demonstrated that mutation of all
C and N terminal lysine of Kv1.2 to arginine diminish this effect, and evidence was
provided to demonstrate that Trim32 is able to ubiquitylate Kv1.2 in vitro at both N and
C termini. To determine if the Trim32 induced increase of surface Kv1.2 is dependent
solely on either channel termini, we repeated the co-expression experiments of Chapter 2
at low confluence with Kv1.2WT, Kv1.2KR, and added Kv1.2CKR and Kv1.2NKR
(Figure A:1A) and determined that neither mutant appeared to completely eliminate the
effect, however the overexpression of Trim32 with Kv1.2CKR was not statistically
significant. This suggests both termini of Kv1.2 may be impacted by Trim32 coexpression to produce the final results observed in Chapter 5. Given the sample size (n =
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6 each), greater power and repeat experiments are needed to conclude the degree of
influence Trim32 has either mutant channel.
Kvβ2 is Not Necessary for Trim32-induced Increase of Surface Kv1.2
Kv1.2 and other Kv1 alpha subunit channels can associate with cytoplasmic
accessory proteins called Kvβ subunits typically in a 1:1 stoichiometry. In the cerebellar
tissue homogenates of Chapter 2, ~ half as many Kvβ subunits peptides were detected as
were alpha subunits. Kvβ subunits, particularly Kvβ2, can impact modulation of gating,
stability, and trafficking of the channels. Co-expression of all Kvβ subunits (1-3) with
Kv1.2 alpha subunit promotes surface expression of Kv1.2 (Campomanes et al., 2002).
To minimize complexity, overexpression experiments reported in Chapter 2 were
performed in HEK cells stably expressing Kvβ2. To investigate whether Kvβ2 influences
Trim32 modulation of surface Kv1.2, we repeated the co-expression of Kv1.2 and
Trim32 in HEK293-ATTC cells lacking Kvβ2 (Figure A:1B). Kvβ2 was co-expressed
into replicate experiments as a control. Empty vector was also co-expressed in cells not
transfected with Kvβ2. No significant difference was found between the two cell lines
under identical conditions, suggesting that Kvβ2 is not significant contributing to the
Trim32-induced increase of surface Kv1.2.
C24A Mutation of Trim32 Does Not Alter Trim32 Trafficking of Kv1.2
Mutation of cysteine 24 to alanine within Trim32’s RING domain has been
previously reported to cause crippling of Trim32 ubiquitin ligase activity. Within the
experiments used to determine Trim32∆RING’s effect on Kv1.2 surface expression in
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Chapter 2, Trim32C42A was also co-expressed with Kv1.2 and determined to have no
significant change to Trim32 induced modulation of surface Kv1.2 Figure A:1C).
Inhibition of Clathrin-dependent Endocytosis Enhances Trim32-induced Increase of
Surface Kv1.2
Chapter 2 did not explicitly investigate whether the effect of Trim32 on surface
Kv1.2 influences trafficking of the channel. Clathrin-dependent endocytosis is a major
internalization mechanism for decreasing Kv1.2 from the PM in HEK cells (Nesti et al.,
2004; Stirling et al., 2009). Given the results of Chapter 2, where Trim32 promoted
Kv1.2 at the cellular membrane at lower confluence conditions, we wondered if
inhibiting clathrin-dependent endocytosis would enhance the Trim32-induced increase of
Kv1.2. To test this, a cell-permeable inhibitor of dynamin, an essential component for
clathrin-dependent coated vesicle formation (Macia et al., 2006), was applied to plated
cells co-expressing Kv1.2 and either Trim32WT, Trim32∆RING, Trim32C24A, or mUb
and the surface expression of Kv1.2 was observed. As with previous experiments, coexpression of Trim32WT, Trim32C24A, or mUb all significantly increased surface
Kv1.2 while Trim32∆RING did not in vehicle treated cells. In cells treated with the
dynamin inhibitor (Dynasore), with the exception of mUb, all of these increases were
significantly enhanced after the treatment of Dynasore (Trim32WT **, Trim32∆RING
***, Trim32C24A***) by two-way ANOVA test. This enhancement may be a result of
blocking endogenous trafficking mechanisms in HEK cells, possibly also incorporating
Trim32’s mechanism to decrease surface Kv1.2 observed in highly confluent cells,
however these details were not investigated and require further experiments.
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Co-immunoprecipitate of Trim32 with Kv1.2 was not observed by Immunoblot from
Tissue Lysed in Buffer Lacking DUB, Proteasome, and Phosphatase Inhibitors
Chapter 2 detected only three peptides of Trim32 by mass spectrometry following
IP of Kv1.2 from tissue lysed in a limited buffer (MS trail 1). To test whether this was a
limitation of experimental detection by mass spectrometry, we immunoprecipitated either
Kv1.2 or Trim32 from tissue lysed in the same buffer containing protease inhibitors
(HALT cocktail of 100mM AEBSF*HCl, 80µM Aprotinin, 5mM Bestatin, E-64, 1.5mM
EDTA, 2mM Leupeptin, and 1mM Pepstatin A) but lacking DUB, proteasome, and
phosphatase inhibitors and used Immunoblotting to detect a potential co-IP (Figure A:2).
Unlike the IB analysis of Chapter 2, which performed the same IPs from tissue lysed also
in 1mM NaF, 1mM NaOrthovanadate, 20mM BAPTA, 5mM NEM, 10 µM MG-132, coIP of either protein under these conditions was not detected. This data suggests that the
preservation of the Kv1.2 and Trim32 association is sensitive to removal of posttranslational modifications. These inhibitors are not specific to Kv1.2 or Trim32 and
further experiments are needed to elaborate the conclusions.
Trim32 Co-expression Promotes High Molecular Weight Bandshifts of Kv1.2 Detected by
Immunoblot.
Chapter 2 highlighted the ~8.5kDa bandshift increases of Kv1.2 following coexpression of Trim32 (or mUb). At the top portion of the gel (< 300kDa), faint, highmolecular weight bandshifts of Kv1.2 can also be detected following Trim32 coexpression. These bandshifts were seen in replicate experiments (Figure A:3A left and
right) and not seen with co-expression of empty vector.
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The RING Domain of Trim32 is not Required for the Trim32 association with Kv1.2
To determine if Trim32s catalytic RING domain is essential for its association
with Kv1.2, Kv1.2 was overexpressed alone, with wild-type Trim32, or with Trim32
lacking the RING domain (Figure A:3B). Cells were lysed and prepared for Kv1.2 IP
and immunoblot as described in Chapter 2 for tissue IB. Regardless of the RING domain,
Trim32 was still detected to co-IP with Kv1.2, suggesting that the catalytic RING domain
is not essential for associating with Kv1.2. Red arrows in the Trim32 co-IP channel
indicate Trim32 and the decreased MW as a result of the deleted RING domain.
AC Activation by Forskolin Alters the Influence of Trim32 on C-terminal
Phosphorylation Sites of Kv1.2
Under identical conditions to those described in Chapter 2, a parallel SILAC
experiment was performed to determine the effect of Trim32 and Forskolin treatment, as
the AC/PKA activator Forskolin has shown previously shown to influence activity of
both Kv1.2 and Trim32 (Connors et al., 2008; Ichimura et al., 2013). The SILAC results
of Chapter 2 are also listed as the vehicle treatment (Table A:1). As reported in Chapter
2, co-expression of Trim32 caused no change in S440 phosphorylation but significantly
decreased S434 phosphorylation. In cells treated with Forskolin, however, Trim32 now
significantly decreased S440 phosphorylation and did not alter S434. These results
suggest that AC activation by Forskolin treatment is able to manipulate the influence of
Trim32 on Kv1.2 phosphorylation. L = Light amino acid (K/R 12C & 14N) containing
culture media and H = Heavy amino acid (K/R 13C & 15N) containing culture media.
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Trim32 is Present Throughout the Mammalian Brain
In addition to isolated cerebellar slices of Chapter 2, a whole brain
immunofluorsecent survey of Trim32 was performed by multiphoton imaging on whole
brain, sagittal slices (Figure A:4, top left shows a cropped picture from a whole, sagittal
image). Trim32 was found to be highly prevalent in the hippocampus particularly
(Figure A:4, top right), where triple staining with Kv1.2 and DAPI showed that Trim32
can also be found within the nuclei of hippocampal cells containing Kv1.2 (Figure A:4,
bottom images). Both the cerebellar finding of Chapter 2 and hippocampal findings here
are in agreement with recent IHC reports of human (both male and female) tissue
provided by proteinatlas.org. Sagittal slices were cut between 10-50 µM thick,
permeabilized in 0.3% Triton X. Slices were prepared for immunofluorescence and
analyzed by microscopy through methods described in Chapters 2 and 3.
Additional Mass Spectrometry Detection of Trim32
A modified table of detection of Trim32 by LC-MS/MS which includes the
addition of the 4 cerebellum homogenate detected by an Orbitrap mass spectrometer
listed in Chapter 3 (Table A:2).
Figure Legends
Figure A:1. Additional flow cytometry data pertaining to Trim32 and ubiquitylation
surface regulation of Kv1.2. (A) Trim32s influence on Kv1.2 is altered by C or N
terminal lysine mutations. Figures 5 and 6 demonstrated that Trim32 modulates surface
Kv1.2 differently dependent on cellular conditions. Here, we tested Trim32
overexpression on N and C terminal KR mutants and compared the results to both
146

Kv1.2WT and KV1.2KR. In this experiment, Trim32 caused a typical significant increase
in surface Kv1.2WT also causing a significant decrease in surface Kv1.2KR.
Overexpressing Trim32 with either Kv1.2-CKR or Kv1.2-NKR caused a modest increase
in surface channel, with NKR but not CKR being significantly different from Kv1.2WT.
N = 6 for each condition. * denotes significance of p < 0.05 by students t-test.
(B) Trim32 does not require Kvβ2 to increase surface Kv1.2. Chapter 2 focused solely on
Trim32 influence toward Kv1.2 alpha subunit. Using HEK293-ATTC cells, we found
that removing Kvβ2 decreased baseline surface Kv1.2 but had no significant effect on
Trim32 increasing Kv1.2 at the membrane surface. N = 6 for each Kv1.2 + vector
condition and n = 12 for Kv1.2 + Trim32 conditions.
(C) GFP-Trim32C24A traffics Kv1.2 similarly to GFP-Trim32WT. It has been
suggested that the cysteine within Trim32’s RING domain is responsible for much of its
ligase activity, and in some assays, replacement with an alanine can partially or
completely cripple ligase activity. Alongside the same experiments run in Figures 5 and
6, we observed that GFP-Trim32C24A altered surface Kv1.2 similarly and not
significantly different to GFP-Trim32WT.
(D) Dynamin inhibition enhances Trim32 increase of surface K1.2. To investigate the
effect of inhibiting clathrin-dependent endocytosis to plated cells co-expressing Kv1.2
and Trim32WT, Trim32∆RING, Trim32C24A and mUb, cells were treated the dynamin
inhibitor Dynasore and compared to DMSO vehicle controls. Dynasore significantly
enhanced the increase of surface Kv1.2 by all Trim32 constructs, but not mUb. N = 6 for
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each condition. Data analyzed by 2way analysis of variance. * = p <0.05 ** = p <0.01***
= p <0.001 **** = p <0.0001.
Figure A:2. Co-immunoprecipitation of Trim32 with Kv1.2 is not detected in
cerebellar extracts without DUB, proteasome, and phosphatase inhibitors present in
lysis buffer.
To determine whether the low Trim32 co-IP detected by LC-MS/MS from tissue
homogenized in lysis buffer lacking 1mM NaF, 1mM NaOrthovanadate, 20mM BAPTA,
5mM NEM, 10 µM MG-132, the experiment was repeated and subject to WB analysis.
No visible co-IP from either Kv1.2 or Trim32 IP was visibly detected.

Figure A:3. Kv1.2 interacts with Trim32 in the absence of its RING domain. A: Wild
type Kv1.2 was expressed alone (+empty vector) or co-expressed with either GFPTrim32WT. Cells were lysed and Kv1.2 protein was detected by immunoblot. Coexpression of Trim32 with Kv1.2 produces high molecular weight bandshifts of Kv1.2
detected in either the cell lysates or following IP of Kv1.2.
B: Wild type Kv1.2 was expressed alone (+empty vector) or co-expressed with either
GFP-Trim32WT or GFP-Trim32∆RING in HEK293β2cells. Cells were lysed in the
presence of MS Trial 3 in Chapter 2, and lysates were IP’d for Kv1.2. Proteins were
separated by SDS-PAGE electrophoresis and analyzed by immunoblot. Probing for
Trim32, a band of Trim32 (~100kDa) was detected from Kv1.2 + GFP-Trim32WT
(Middle lane). A band of Trim32 was still detected from cells co-expressing Kv1.2 +
GFP-Trim32∆RING (Right lane) with an appropriate decrease of molecular weight
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corresponding to the deleted RING domain. Lysates show total Kv1.2 and Trim32
proteins in both conditions, and molecular weight for Trim32 was similarly decreased
form cultures expressing the RING mutation.
Figure A:4. Trim32 is present throughout the rat brain. Beside the cerebellum, Kv1.2
is endogenously expressed in other cortical regions of the brain such as the hippocampus.
Top panel- multiphoton analysis of fixed cerebellar slices demonstrated that Trim32 is
diffuse throughout the brain (left), particularly in the hippocampus where Kv1.2 is highly
expressed (right). Full brain sagittal images: Adult rat cerebellar slices (400 µM) were
fixed (2% formaldehyde cardiac perfusion), permeabilized (10% acetone), blocked, and
stained for Kv1.2 (1:200) and Trim32 (1:100), and imaged using a Zeiss LSM 7
multiphoton microscope and a 20X water lens. Images were analyzed in Zen 2011
Software. Bottom panel- Widefield/deconvolution (Deltavision) images demonstrated
Trim32 localizes to the nucleus of neurons expressing Kv1.2 within the hippocampus.
Images obtained at 60X magnification with the same method and parameters listed in
Chapter 2.

Table A:1. Table of SILAC quantification that includes the result of Chapter 2 and
a parallel experiment with Forskolin treatment. The SILAC results of Chapter 2 are
listed as the vehicle treatment and compared to a parallel experiment with both Light and
Heavy populations treated with Forskolin. Rather than decreasing S434 phosphorylation,
Trim32 co-expressed cells treated with Forskolin now significantly decreased S440
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phosphorylation and did not alter S434. Culture media in the Light population contained
lysine and arginine amino acids with K = 12C6 & 14N2 and R = 12C6 & 14N4) while Heavy
populations contained them with K = 13C6 & 15N2 and R 13C6 & 15N4.
Table A:2. Additional detection of Trim32 by LC-MS/MS. A modified table of
detection of Trim32 by LC-MS/MS which includes the addition of the 4 cerebellum
homogenate detected by an Orbitrap mass spectrometer listed in Chapter 3.
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Figure A:1 Additional flow cytometry data pertaining to Trim32 and ubiquitylation
surface regulation of Kv1.2.
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Figure A:2 Co-immunoprecipitation of Trim32 with Kv1.2 is not detected in
cerebellar extracts without DUB, proteasome, and phosphatase inhibitors present in
lysis buffer.
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Figure A:3 Kv1.2 interacts with Trim32 in the absence of its RING domain.
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Figure A:4 Trim32 is present throughout the rat brain.
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Table A:1 Table of SILAC quantification that includes the result of Chapter 2 and a
parallel experiment with Forskolin treatment.
S440

S440

S434
Unmodified

S434
Phoshphorylated

unmodified

Phosphorylated

Kv1.2 + Trim32

H/L = 1.25

H/L =1.18

H/L =1.67

H/L =0.77

Kv1.2 + Trim32

H/L = 0.59

H/L = 0.25

H/L = 0.63

H/L = 0.53

+ Forskolin

Table A:2 Additional detection of Trim32 by LC-MS/MS.
MS Trial

1

2

3

4

2 cerebellum

2 cerebellum

2 cerebellum

4 cerebellum

PTM conditions*

NO

YES

YES

YES

Protein XCorr

3.25

3.57

3.13

3.33

Total Peptides

3

11

11

12

Tissue
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APPENDIX B: DATA RELATING TO CHAPTER 3
Background
The data presented here were collected during the experiments presented in
Chapter 3 but were not included in the final six figures. Similarly to Appendix A for
Chapter 2, this data is intended to expand the clarity and depth of Chapter 3.
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Results and Discussion
Hypertonic Stress Alters WNK1-Induced Modulation of Surface Kv1.2 in WNK1KO 293T
but not Control 293T Cells.
Since co-expression of WNK1 alters surface Kv1.2 in HEK293 cells, and WNK1
is an intrinsic sensor of cell volume, we wondered if altering extracellular tonicity would
impact the influence WNK1 has on Kv1.2 surface expression. High extracellular NaCl
produces a hypertonic extracellular environment which has previously been shown to
stimulate autophosphorylation and activation of endogenous WNK1 in HEK cells (B. Xu
et al., 2000). Hyperosmotic stress also induces a rapid localization of WNK1 to clathrincoated vesicles (Zagorska et al., 2007). Just as Chapter 3, experiments were performed in
both HEK293T-cells and WNK1KO cells co-expressing Kv1.2 and WNK1 (or empty
vector). Surface Kv1.2 in cells treated with high NaCl (0.4M, 20 minutes) was compared
to isotonic controls treated with vehicle (PBS) (Figure B:1). High extracellular NaCl
alone had no effect on Kv1.2 surface expression (+3%, t(df) = 0.44(16), p = 0.6629, n =
12 (isotonic), 6 (hypertonic), and co-transfection of WNK1 caused a significant decrease
of surface Kv1.2 similar to isotonic conditions (-12%, t(df) = 2.96(10), p < 0.05, n = 12
(isotonic), 6 (hypertonic). As observed in Chapter 3, switching from HEK293T-cells to
WNK1KO cells significantly decreased baseline Kv1.2 (-9%, t(df) = 2.28(10), p < 0.05,
n = 12 (isotonic), 6 (hypertonic). However, unlike isotonic conditions, co-transfection of
WNK1 in WNK1KO cells caused a significant decrease of surface Kv1.2 (-15%, t(df) =
2.34(10), p <0.05, 12 (isotonic), 6 (hypertonic) after NaCl exposure, suggesting that the
mechanism driving increased surface Kv1.2 does not occur during hypertonic stress. In
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addition to activation of WNK kinases, hypertonic stress promotes both the binding and
activation of downstream SPAK/OSR1 kinases by WNK kinases (Zagorska et al., 2007),
supporting the idea that the decrease of surface Kv1.2 by Trim32 over-expression is
through SPAK activation.
WNK1 Localizes to Ring-like Structures in PC Soma
In a repeat IF experiment for Chapter 3, again, WNK1 is strongly localized in the
molecular layer with Kv1.2, however WNK1 also displays a unique, ring-like structures
within the PC bodies (Figure A:2A Top panel). Additionally, WNK1 also is found with
punctate structures that surround the cell body of the PC which overlap with Kv1.2. A
magnification of a PC soma with a surrounding Pinceau is provided for further clarity
(Figure A:2A, insert). Further experiments are needed to determine whether the ring-like
structure is in fact nuclear or peri-nuclear in localization as well as to determine the true
function of the puncta.
SPAK May also Localize to Purkinje Cells
Given the localization of WNK1 determined in Chapter 3, and the fact that
WNK1 and SPAK share a similar signaling pathway, SPAK is likely also localized to
PCs and molecular layer neurons. Using multiphoton imaging similar to Chapter 3,
SPAK was also detected, although at weaker resolution, within all cerebellar locations,
most particularly in PCs and within the molecular layer by multiphoton microscopy
(Figure B:2B, Middle panel). Additional imaging with high magnification (100X)
widefield microscopy with DeltaVision restoration demonstrated SPAK diffuse within

162

the molecular layer and PCs (Figure B:2B, Bottom panel). Perinuclear ring-like
structure similar to that seen with WNK1 by multiphoton (Figure B:2B, Insert).
SPAK Peptide Fragmentation Spectra with Phosphorylation at Threonine T240
SPAK is phosphorylated and subsequently activated by WNK1 at an equivalent
threonine found across mammals: T233 in human, T243 in mice, and here T240 in rat.
Chapter 3 presented several peptides of SPAK T240 that were found phosphorylated in
cerebellar tissue enriched for Kv1.2, however the spectra were not shown. Figure 3
provides a representative spectra detected from Chapter 3 experiments. Peptide charge =
+3, Xcorr = 2.57, localization determined by manual inspection.
Figure Legends

Figure 1. Extracellular hypertonic treatment of HEK293 cells and response of Kv1.2
surface expression. HEK293T control or WNK1KO cells co-transfected with Kv1.2 and
WNK1 or empty vector were treated with either isotonic or hypertonic (0.4M, NaCl)
media for 20 minutes prior to surface expression measure by flow cytometry. Control
293T cells caused a significant decrease of surface Kv1.2 in both conditions, and
hypertonic media alone did not alter baseline expression of Kv1.2. Switching from T
cells to WNK1KO cells, as before, decreased baseline surface Kv1.2 in both conditions,
however co-expression of WNK1 caused a significant decrease of surface channel
equivalent to that of the T cells, rather than the significant increase demonstrated under
prior experiments and isotonic conditions here.
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Figure 2. SPAK localization in the cerebellum and Possible WNK1 trans-golgi and
vesicular localization in cerebellar Purkinje cells. A: Multiphoton imaging
highlighting the ring-like structure that WNK1 (pseudo colored green) often demonstrates
in PC cell bodies. Other cerebellar interneurons (BC, stellate) can be seen as well as what
may be Burgmann Glia between (large, green structures between PCs). Note: colors are
reversed to those of Chapter 3 imaging. B: Imaging of SPAK by both Multiphoton (top)
and Widefield/deconvolution (bottom) Microscopy collectively display what appears as
localization to both PCs and the molecular layer, however repeat experiment with
improved detection are needed.

Figure 3. SPAK T240 phosphorylation spectra in the cerebellum. SPAK is
phosphorylated and subsequently activated by WNK1 at an equivalent threonine found
across mammals: T233 in human, T243 in mice, and here T240 in rat. Chapter 3
presented several peptides of SPAK T240 and a representative peptide spectra is shown
(Peptide charge = +3, Xcorr = 2.57). All LC-MS/MS preparation and analysis were
identical to those described in Chapter 3.
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Figure B:1 Extracellular hypertonic treatment of HEK293 cells and response of
Kv1.2 surface expression.

165

Figure B:2 SPAK localization in the cerebellum and Possible WNK1 trans-golgi and
vesicular localization in cerebellar Purkinje cells.
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Figure B:3 SPAK T240 phosphorylation spectra detected in cerebellar tissue
immunoprecipitated for Kv1.2.
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Table B:1 MS detection of SPAK.
MS Trial

1

2

3

4

5

Tissue

2 cerebellum

2 cerebellum 2 cerebellum 2 cerebellum 4 cerebellum

PTM conditions*

NO

YES

YES

YES

YES

Protein XCorr

3.29

3.94

3.81

3.65

3.71

Total Peptides

21

9

9

14

13

Table B:2 MS detection of WNK1.
MS Trial

1

2

3**

Tissue

2 cerebellum

6 cerebellum

2 cerebellum

PTM conditions*

YES

YES

YES

Protein XCorr

2.87

2.81

2.87

Total Peptides

12

14

7
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APPENDIX C: ADDITIONAL MASS SPECTROMETRY DATA
Background
This section provides supplementary mass spectrometry data which was obtained
throughout the generation of Chapters 2 and 3.
Results and Discussion
Forskolin Alters S440 Phosphorylation of Kv1.2 in Cerebellar Slices
Recently, application of the neuropeptide secretin to live cerebellar slices was
shown to result in altered trafficking of Kv1.2 through AC/PKA activation (Williams et
al., 2012). As mentioned in previous chapters, AC stimulation by Forskolin treatment has
also been shown to alter S440 phosphorylation in HEK293 cells (Connors et al., 2008).
To test whether stimulation of AC/PKA to cerebellar slices leads to altered
phosphorylation at S440, we stimulated live slices with Forskolin and used Absolute
Quantification of Peptides (AQUA) quantitative MS analysis. The AQUA peptide was
identical to the commonly detected doubly charged, singly phosphorylated peptide
IPSpSPDLKK with the addition of 13C6 to the leucine (L444) and was detected prior to
experimentation at 526.38 m/z. AQUA analysis showed that Forskolin treated slices
resulted in ~50% increased S440 phosphorylation compared to DMSO vehicle treated
slices (Figure C:1). Because of overall weak detection of Kv1.2 in the samples, MS2
fragmentation spectra was not obtained for all +2 peptides quantified and therefore S441
phosphorylation cannot be ruled out and interpretation may therefore be limited to
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combined S440 and S441 phosphorylation. Regardless, AC/PKA activation by Forskolin
treatment appears to impact both surface expression (Williams et al., 2012) and
phosphoryalation of Kv1.2 in cerebellar slices.
Kv1.2 Post-translational Modifications Detected by LC-MS/MS with Unknown
Functionality
A recent, large-scale proteomic study reported a peptide of Kv1.2 ubiquitylated at
K45 and K63 isolated from mouse tissue (Wagner et al., 2012). In Chapter 2, we reported
identification of these two sites on a single peptide detected in MS Trial 2. The spectra is
presented here in Figure C:2. Mass addition of lysine 45 was well localized (b5, b6 and
y16 ions detected), however, mass addition by di-GG of adjacent K63 and K64 was
difficult to localize (although y2, y3, and b19 were suggestive of K63). The peptide
charge was +3 with a Sequest Xcorr value of 2.2. Sample preparation and analysis by
LC-MS/MS was identical to Chapter 2. Functional roles for these sites remained to be
elucidated.
Another site of Kv1.2 modulation detected in mouse tissue by Wagner et. al. was
serine 468 phosphorylation. This site has not been reported in rat tissue or localized to the
cerebellum, nor does a functional role for this PTM exist. We detected this site
abundantly phosphorylated in cerebellar tissue (Xcorr values as high as 5.0). An example
spectra is shown in Figure C:3 (Charge = +3, Xcorr = 5.4, A score = 119). Additionally,
detection of phosphosites of this peptide by LC-MS/MS analysis following cerebellumdependent learning in Chapter 3 was noted, however a functional link was not determined
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nor were the results truly quantitative. Further validation is needed to determine whether
phosphorylation of S468 is truly related to cerebellum-dependent learning.
Comparison of Kv1.1 S439 and Kv1.2 Modified Peptides
Sequence alignment of Kv1.2 with that of Kv1.1 shows that Kv1.1 does not have
a homologous lysine or arginine in this region of its C-terminus (Figure 5). The resultant
tryptic peptide is of similar length to the peptide of Kv1.2 with K437 ubiquitylation.
Serine 439, homologous to S440 of Kv1.2, was often detected phosphorylated and
produced a tryptic peptide with similar length and general fragmentation pattern for
comparison of Kv1.2 K437 ubiquitylation.
Figure Legends

Figure C:1. Forskolin alters S440 phosphorylation of Kv1.2 in vivo. Treatment of
Forskolin (100µM, 15min) to cerebellar slices resulted in approximately twice as many
Kv1.2 S440 phosphopeptides compared to DMSO vehicle treated slices as detected by
Absolute Quantification LC-MS/MS (run on an LTQ Orbitrap Discovery mass
spectrometer with mass accuracy ~0.05Da). Figure shows MS1 spectra and LC elution
insert from DMOS condition only. Spectra demonstrates successful detection of both
light (endogenous) and heavy (synthetic) peptides, while quantitative ratios of light/heavy
peptides listed below demonstrate a change between conditions.
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Figure C:2. N-terminal Kv1.2 ubiquitylated peptide detected by MS. Ubiquitylation
at K45 and K63 was detected on a single peptide from MS trail 2. Within the peptide, the
first –GG motif was well localized to K45 while other was likely at K63 upon manual
inspection of fragmentation, although K64 was not able to be ruled out (Peptide charge
+3, Xcorr = 2.2). Preparation of sample and analysis of LC-MS/MS was described in
Chapter 2 (Also pertains to Figure C:3 and Figure C:4 below).

Figure C:3. Peptide fragmentation spectra of Kv1.2 phosphorylation at S468.
Phosphopeptides containing serine 468 phosphorylation were detected in all tissue
experiments and mentioned in the behavioral experiment of Chapter 3. A representative
fragmentation spectra of this phosphopeptide is shown (Charge = +3, Xcorr = 5.44, A
score = 119).

Figure C:4. Kv1.1 Sequence and fragmentation spectra comparison of Kv1.2 437
ubiquitylation and Kv1.1 S439 phosphorylation. Kv1.1 does not possess a lysine or
arginine equivalent to the region of Kv1.2 K437, and tryptic peptides are cut in similar
length to the commonly detected +3 K437 ubiquitylated peptide of Kv1.2. This peptide
was often detected phosphorylated at a S439, homologous to S440 of Kv1.2. The two
peptides are presented together for qualitative assessment.
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Table 1. Total PTMs detected by LC-MS/MS for Kv1.2. A comprehensive list of all
PTMs identified in cerebellar tissue by mass spectrometry. All sites were identified by
matching LC-M/MS fragmentation spectra to Sequest database spectra with mass
tolerance of +/- 1 Da. Localization of all PTMs were confirmed by manual inspection.
Table 2. Total PTMs detected by LC-MS/MS for Kv1.1. A comprehensive list of all
PTMs identified in cerebellar tissue by mass spectrometry similarly to Table 1 for Kv1.2.

Table 3. Complete Linear Quadrapole LC-MS/MS interactome of Kv1.2 from
Chapter 2 MS trail 1. All proteins identified contained at least 3 unique peptides
detected in the experimental and none detected in the equivalent controls.

Table 4. Complete Liner Quadrapole LC-MS/MS interactome of Kv1.2 from
Chapter 2 MS trails 2 and 3 combined (3 includes entire gel). As Table 2, all proteins
identified contained at least 3 unique peptides detected in the experimental and none
detected in the equivalent controls.
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Figure C:1 Forskolin alters S440 phosphorylation of Kv1.2 in vivo.
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Figure C:2 N-terminal Kv1.2 ubiquitylated peptide detected by MS.
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Figure C:3 Peptide fragmentation spectra of Kv1.2 phosphorylation at S468.

176

Figure C:4 Kv1.1 Sequence and fragmentation spectra comparison of Kv1.2 437
ubiquitylation and Kv1.1 S439 phosphorylation.
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Table C:1 Total PTMs detected by LC-MS/MS for Kv1.2.
Site

Best Score

# experiments

Localization

Charge

Location

S434

Xcorr = 4.3

4

A score = 143

+2/+3

C-term

S440

Xcorr = 2.9

2

PhosphoRS =
95.5%

+2

C-term

S441

Xcorr = 2.9

4

A score = 76

+2

C-term

pRS = 99.8%
S440/S441

Xcorr = 2.8

3

100%

+2

C-term

S449

Xcorr = 1.7

1

Manual

+2

C-term

S468

Xcorr = 5.4

3

A score = 119

+2

C-term

S308/S311

Xcorr = 2.3

4

A score = 37, 37

+2

S4 voltage
sensing domain

K437

Xcorr = 2.4

4

Manual

+3

C-term

K478

Xcorr = 1.86

2

100%

+3

C term

K45/K63 or
K64

Xcorr = 2.16

1

Manuel

+3

N-term

Table C:2 Total PTMs detected by LC-MS/MS for Kv1.1.
Site

Best Score

# experiments

Localization

Charge

Location

S5

Mascot score
82

2

Manuel

+3

N-term

S23

Mascot score
77

2

PhosphoRS =
83.3%

+3

N-term

S13

Xcorr = 2.7

1

+2

N-term

T2/S5

Xcorr = 4.0

2

pRS 100%,
100%

+3

N-term

S439

Xcorr = 4.3?

3

A = 17

+2

C-term
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Table C:3 Complete Interactome of Kv1.2 from Chapter 2 MS trial 1.
Unique

Total

AVG

Gene Symbol

16
14
11
10
10
10
8
8
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3

29
22
16
20
18
12
14
9
8
7
7
7
5
5
4
6
5
4
3
3
3
3
3

3.6772
3.6861
3.6226
3.8376
3.4533
3.3173
3.7763
3.4153
3.3389
3.0597
4.0188
3.7124
2.639
2.6042
2.6181
3.1888
2.9615
2.8513
3.7825
3.3863
3.244
2.8208
2.7644

Kcna1
Atp1a2
Atp2a2
Kcna2
Stk39
Nsf
Atp1a1
Atp1a3
Hspa2
Slc1a6
Kcna6
Hspa1b;Hspa1a
Atp5b
Slc25a13
RGD1561141
Hspa5
Tubb5
Kcna4
Kcna3
Sv2a
Trim32
Pfkm
Slc1a2

Table C:4 Complete Interactome of Kv1.2 from Chapter 2 MS trials 2 and 3 .
Unique

Total

Protein X Corr

Gene Symbol

MS trial identifed

17
17
17
16
15
14
12
10
10
10
9

78
54
78
33
25
22
16
19
15
12
22

3.51
3.8551
3.51
3.6003
3.4195
3.931
3.5827
3.5618
3.4622
2.8711
3.3511

Kcna1
Kcna2
Kcna1
Kcnab2
Pfkp
Dpysl4
Kcnab1
Immt
Skiv2l2
Wnk1
Trim32

2 and 3
2 and 3
2 and 3
2 and 3
2 and 3
2 and 3
2 and 3
2 and 3
3
3
2 and 3
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9
7
7
6
6
6
6
6
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
3

15
18
16
25
9
8
8
8
8
7
7
7
10
9
8
8
7
18
7
7
6
6
6
5
5
4
4
8

4.0641
3.5462
3.872
3.6932
3.2571
3.6751
3.5669
3.3293
2.801
3.3236
3.1803
3.1
3.5057
3.3113
4.2538
3.4364
3.4613
3.8773
3.6878
3.3739
3.4102
3.197
2.6938
3.3018
3.2709
3.4811
3.0065
3.5911

Idh3B
Prkcg
Acsbg1
Kcna3
Ap1b1
Cct6a
Ap2a1
UNCHARACTERIZED
RGD1307284
Gls
Irs2
Maoa
Kcna4
RGD1309586
Pfkl
Copa
Dlg2
Stk39
Idh2
Kif5c
Rars
Hspa12a
Atad3a
Dmxl2
Aldh1l1
Iars2
Map1b
Ddx5
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3
2 and 3
2 and 3
2 and 3
2 and 3
2 and 3
3
3
3
2 and 3
3
3
2 and 3
2 and 3
2 and 3
2 and 3
2 and 3
2 and 3
3
3
2 and 3
2 and 3
3
3
2 and 3
3
2 and 3
2 and 3
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